MicroRNA-372 acts as a double-edged sword in human cancers

MicroRNAs (miRNAs or miRs) are non-coding, single-stranded, endogenous RNAs that regulate various biological processes, most notably the pathophysiology of many human malignancies. It process is accomplished by binding to 3′-UTR mRNAs and controlling gene expression at the post-transcriptional level...

Full description

Saved in:
Bibliographic Details
Published inHeliyon Vol. 9; no. 5; p. e15991
Main Authors Tajik, Fatemeh, Alian, Fatemeh, Yousefi, Mohammad, Azadfallah, Ali, Hoseini, Aref, Mohammadi, Forogh, Karimi-Dehkordi, Maryam, Alizadeh-Fanalou, Shahin
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.05.2023
Elsevier
Subjects
Cancer
carcinogenesis
Function
gene expression
humans
Importance
microRNA
MicroRNA-372
neoplasm progression
neoplasms
Oncogene
oncogenes
pathophysiology
Review
therapeutics
Tumor suppressor
Importance
Function
MicroRNA-372
Tumor suppressor
Oncogene
Cancer
Online AccessGet full text
ISSN2405-8440
2405-8440
DOI10.1016/j.heliyon.2023.e15991

Cover

Abstract MicroRNAs (miRNAs or miRs) are non-coding, single-stranded, endogenous RNAs that regulate various biological processes, most notably the pathophysiology of many human malignancies. It process is accomplished by binding to 3′-UTR mRNAs and controlling gene expression at the post-transcriptional level. As an oncogene, miRNAs can either accelerate cancer progression or slow it down as a tumor suppressor. MicroRNA-372 (miR-372) has been found to have an abnormal expression in numerous human malignancies, implying that the miRNA plays a role in carcinogenesis. It is both increased and downregulated in various cancers, and it serves as both a tumor suppressor and an oncogene. This study examines the functions of miR-372 as well as the LncRNA/CircRNA-miRNA-mRNA signaling pathways in various malignancies and analyses its potential prognostic, diagnostic, and therapeutic implications.
AbstractList MicroRNAs (miRNAs or miRs) are non-coding, single-stranded, endogenous RNAs that regulate various biological processes, most notably the pathophysiology of many human malignancies. It process is accomplished by binding to 3'-UTR mRNAs and controlling gene expression at the post-transcriptional level. As an oncogene, miRNAs can either accelerate cancer progression or slow it down as a tumor suppressor. MicroRNA-372 (miR-372) has been found to have an abnormal expression in numerous human malignancies, implying that the miRNA plays a role in carcinogenesis. It is both increased and downregulated in various cancers, and it serves as both a tumor suppressor and an oncogene. This study examines the functions of miR-372 as well as the LncRNA/CircRNA-miRNA-mRNA signaling pathways in various malignancies and analyses its potential prognostic, diagnostic, and therapeutic implications.MicroRNAs (miRNAs or miRs) are non-coding, single-stranded, endogenous RNAs that regulate various biological processes, most notably the pathophysiology of many human malignancies. It process is accomplished by binding to 3'-UTR mRNAs and controlling gene expression at the post-transcriptional level. As an oncogene, miRNAs can either accelerate cancer progression or slow it down as a tumor suppressor. MicroRNA-372 (miR-372) has been found to have an abnormal expression in numerous human malignancies, implying that the miRNA plays a role in carcinogenesis. It is both increased and downregulated in various cancers, and it serves as both a tumor suppressor and an oncogene. This study examines the functions of miR-372 as well as the LncRNA/CircRNA-miRNA-mRNA signaling pathways in various malignancies and analyses its potential prognostic, diagnostic, and therapeutic implications.
MicroRNAs (miRNAs or miRs) are non-coding, single-stranded, endogenous RNAs that regulate various biological processes, most notably the pathophysiology of many human malignancies. It process is accomplished by binding to 3′-UTR mRNAs and controlling gene expression at the post-transcriptional level. As an oncogene, miRNAs can either accelerate cancer progression or slow it down as a tumor suppressor. MicroRNA-372 (miR-372) has been found to have an abnormal expression in numerous human malignancies, implying that the miRNA plays a role in carcinogenesis. It is both increased and downregulated in various cancers, and it serves as both a tumor suppressor and an oncogene. This study examines the functions of miR-372 as well as the LncRNA/CircRNA-miRNA-mRNA signaling pathways in various malignancies and analyses its potential prognostic, diagnostic, and therapeutic implications.
ArticleNumber e15991
Author Karimi-Dehkordi, Maryam
Alizadeh-Fanalou, Shahin
Alian, Fatemeh
Yousefi, Mohammad
Mohammadi, Forogh
Hoseini, Aref
Tajik, Fatemeh
Azadfallah, Ali
Author_xml – sequence: 1
  givenname: Fatemeh
  surname: Tajik
  fullname: Tajik, Fatemeh
  organization: Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran
– sequence: 2
  givenname: Fatemeh
  surname: Alian
  fullname: Alian, Fatemeh
  organization: Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
– sequence: 3
  givenname: Mohammad
  surname: Yousefi
  fullname: Yousefi, Mohammad
  organization: Department of Medicine, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran
– sequence: 4
  givenname: Ali
  orcidid: 0000-0002-9846-7885
  surname: Azadfallah
  fullname: Azadfallah, Ali
  organization: Department of Medicine, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran
– sequence: 5
  givenname: Aref
  surname: Hoseini
  fullname: Hoseini, Aref
  organization: Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
– sequence: 6
  givenname: Forogh
  surname: Mohammadi
  fullname: Mohammadi, Forogh
  email: F_mohammadi@iauksh.ac.ir, forogh_mo58@yahoo.com
  organization: Department of Veterinary, Agriculture Faculty, Kermanshah Branch, Islamic Azad University, Kermanshah, Iran
– sequence: 7
  givenname: Maryam
  surname: Karimi-Dehkordi
  fullname: Karimi-Dehkordi, Maryam
  email: ma_karimivet58@yahoo.com
  organization: Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
– sequence: 8
  givenname: Shahin
  orcidid: 0000-0003-0448-7074
  surname: Alizadeh-Fanalou
  fullname: Alizadeh-Fanalou, Shahin
  email: alizadeh.sh@umsu.ac.ir, shahin.alizadeh60@yahoo.com
  organization: Department of Clinical Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37251909$$D View this record in MEDLINE/PubMed
BookMark eNqNkk1v1DAQhi1UREvpTwDlyCWLP-MYDqiqoFQqICE4WxN7sutVNi52tlX_PU53qVouxbJkazzzeOz3fUkOxjgiIa8ZXTDKmnfrxQqHcBvHBadcLJApY9gzcsQlVXUrJT14sD8kJzmvKaVMtY3R4gU5FJorZqg5Iu-_Bpfij2-ndYlV4KZcQZmVj9tuwBr9En2Vb2LyVRir1XYDY-VgdJjyK_K8hyHjyX49Jr8-f_p59qW-_H5-cXZ6WTvV6KlWrem9d_NoHADtqHMGTNvITijQjZZCe05Bg9ISDQolutK61z3XClCKY3Kx4_oIa3uVwgbSrY0Q7F0gpqWFNAU3oO0MeEMddbwRkhndeiYY7U1bniu4w8L6uGNdbbsNeofjlGB4BH18MoaVXcZryyinrZG6EN7uCSn-3mKe7CZkh8MAI8ZttrwVstzGOf-PVE6Npo2eqW8e9nXf0F-hSoLaJRS1ck7Y36cwamdP2LXde8LOnrA7T5S6D__UuTDBFOL8vDA8Wb3_Liz6XgdMNruARX0fErqpCBCeIPwB2izTvg
CitedBy_id crossref_primary_10_3389_fimmu_2024_1333563
crossref_primary_10_1038_s41598_025_85502_4
crossref_primary_10_1186_s13000_024_01575_1
crossref_primary_10_1016_j_ymeth_2024_05_001
crossref_primary_10_1016_j_heliyon_2023_e17218
crossref_primary_10_1089_dcbr_2024_0022
crossref_primary_10_1016_j_bbrep_2024_101863
crossref_primary_10_1007_s00210_024_03719_y
crossref_primary_10_3390_ijms241411613
Cites_doi 10.3748/wjg.v25.i17.2029
10.1080/21691401.2018.1457537
10.1080/07357907.2020.1768401
10.1074/jbc.M111.221564
10.1097/PPO.0b013e318258b78f
10.1186/s12938-021-00860-0
10.3892/mmr.2017.7591
10.21037/cco-20-230
10.1053/j.gastro.2020.02.068
10.1038/nrc1997
10.1016/j.genrep.2021.101025
10.1016/j.kint.2018.01.023
10.1186/s12885-018-5175-y
10.1146/annurev-biochem-060308-103103
10.1007/978-3-319-41388-4_19
10.1073/pnas.0510565103
10.1007/s12325-018-0766-1
10.1007/978-0-387-69116-9_2
10.3389/fonc.2020.00047
10.2174/1871520620666200516145830
10.1007/s00401-008-0467-y
10.1002/lary.25464
10.1093/nar/gkq285
10.1158/1078-0432.CCR-11-2347
10.1016/j.omtn.2021.02.006
10.2174/1574892811999160628114857
10.3390/cancers13061396
10.3390/healthcare11030437
10.1002/cam4.1924
10.2174/1871520615666150716110406
10.1080/14737140.2018.1413939
10.1146/annurev.pathol.4.110807.092222
10.1016/j.tiv.2019.03.014
10.18632/oncotarget.3340
10.1074/jbc.RA119.010511
10.1016/S0140-6736(20)30974-0
10.3390/cancers12082130
10.1055/a-0646-4522
10.1002/cam4.1026
10.3389/fonc.2021.780264
10.2174/1381612828666220401143249
10.1111/cpr.12936
10.1016/0092-8674(93)90530-4
10.1002/elps.201100329
10.1053/j.gastro.2020.10.007
10.1186/1471-2407-14-107
10.1002/cncr.33587
10.1016/j.ccm.2011.09.001
10.2147/OTT.S249268
10.1007/s00109-012-0918-8
10.1038/nbt.1862
10.1016/j.canlet.2020.10.004
10.1097/CAD.0000000000000049
10.1016/j.bbrc.2019.10.105
10.1136/gutjnl-2014-308124
10.1111/cpr.12207
10.1089/dna.2021.0330
10.1016/j.gene.2017.04.043
10.3892/ijo.2012.1737
10.1002/cncr.11485
10.1038/sj.onc.1209911
10.1016/j.cell.2006.02.037
10.1016/j.jamcollsurg.2015.07.361
10.1016/S0140-6736(19)30956-0
10.1097/CEJ.0000000000000480
10.1021/cb400668h
10.1038/s41419-020-03083-8
10.1186/1758-907X-2-7
10.1111/bcpt.12687
10.1183/13993003.00359-2016
10.1016/j.bpg.2004.10.004
10.31557/APJCP.2020.21.3.593
10.1002/stem.2378
10.1002/1878-0261.12376
10.1002/jcb.24949
10.1093/carcin/bgs235
10.1016/0092-8674(93)90529-Y
10.1038/mtna.2015.18
10.2174/1566523217666170102105119
10.1002/ijc.31961
10.1021/acsnano.5b02471
10.1016/j.ejca.2014.07.012
10.1016/S0092-8674(01)00616-X
10.1097/MOU.0000000000000452
10.1186/s12885-015-1214-0
10.1101/cshperspect.a030361
10.1097/MOU.0000000000000642
10.12703/r/10-67
10.1111/jcmm.14198
10.5507/bp.2015.050
10.31744/einstein_journal/2021RB5996
10.1186/s12935-023-02851-8
10.1016/j.juro.2014.07.010
10.1089/dna.2015.3186
10.5644/ama2006-124.326
10.3892/mmr.2017.7520
10.1016/j.tranon.2020.100974
10.3390/ijms9060978
10.1155/2020/9160905
10.18632/oncotarget.16260
10.18632/oncotarget.6544
10.2147/CMAR.S244527
10.1093/jnci/djv291
10.1016/j.sxmr.2019.09.005
10.1080/13543784.2017.1324568
10.1159/000336809
10.1038/s41388-020-1236-1
10.1007/s10059-009-0158-0
10.1111/cas.13315
10.1016/j.ymthe.2016.11.016
10.1186/s10020-020-00155-5
10.1200/EDBK_175666
10.1016/j.dld.2011.10.010
10.3802/jgo.2019.30.e46
10.1016/j.ydbio.2006.08.028
10.1101/gad.315739.118
10.1186/s13045-019-0748-z
10.1186/s12935-019-0926-7
10.1038/s41585-020-00400-w
10.1016/S0092-8674(04)00045-5
10.1016/j.drudis.2016.10.014
10.21037/tlcr.2018.05.06
10.1126/science.1149460
10.1016/S0140-6736(21)00153-7
10.2147/IJWH.S197604
10.1002/jcp.30751
10.1101/cshperspect.a030411
10.1016/j.msard.2020.102303
10.1016/j.biopha.2021.111863
10.1038/s41568-019-0177-x
10.1001/jama.2018.19323
10.1152/ajprenal.00480.2016
10.1111/cas.13267
ContentType Journal Article
Copyright 2023 The Authors
2023 The Authors.
2023 The Authors 2023
Copyright_xml – notice: 2023 The Authors
– notice: 2023 The Authors.
– notice: 2023 The Authors 2023
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
7X8
7S9
L.6
5PM
DOA
DOI 10.1016/j.heliyon.2023.e15991
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic


AGRICOLA
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2405-8440
ExternalDocumentID oai_doaj_org_article_b9ad90c0c26341978d1310f9825132ce
PMC10208947
37251909
10_1016_j_heliyon_2023_e15991
S2405844023031985
Genre Journal Article
Review
GroupedDBID 0R~
457
53G
5VS
6I.
AAEDW
AAFTH
AAFWJ
AALRI
AAYWO
ABMAC
ACGFS
ACLIJ
ACVFH
ADBBV
ADCNI
ADEZE
ADVLN
AEUPX
AEXQZ
AFJKZ
AFPKN
AFPUW
AFTJW
AGHFR
AIGII
AITUG
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
APXCP
BAWUL
BCNDV
DIK
EBS
EJD
FDB
GROUPED_DOAJ
HYE
IPNFZ
KQ8
M~E
O9-
OK1
RIG
ROL
RPM
SSZ
AAYXX
CITATION
NPM
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c567t-589fddccccc6caa0b0cc9a9864b35a767437d20a7a574e9e353b405d7f275ae43
IEDL.DBID DOA
ISSN 2405-8440
IngestDate Wed Aug 27 01:29:55 EDT 2025
Thu Aug 21 18:37:41 EDT 2025
Fri Aug 22 20:36:57 EDT 2025
Fri Jul 11 07:36:19 EDT 2025
Mon Jul 21 05:43:38 EDT 2025
Thu Apr 24 22:58:38 EDT 2025
Wed Sep 03 16:35:03 EDT 2025
Sat Aug 16 17:00:58 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Importance
Function
MicroRNA-372
Tumor suppressor
Oncogene
Cancer
Language English
License This is an open access article under the CC BY-NC-ND license.
2023 The Authors.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c567t-589fddccccc6caa0b0cc9a9864b35a767437d20a7a574e9e353b405d7f275ae43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Fatemeh Tajik and Fatemeh Alian equally contributed to the manuscript.
ORCID 0000-0002-9846-7885
0000-0003-0448-7074
OpenAccessLink https://doaj.org/article/b9ad90c0c26341978d1310f9825132ce
PMID 37251909
PQID 2820970677
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_b9ad90c0c26341978d1310f9825132ce
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10208947
proquest_miscellaneous_2834251222
proquest_miscellaneous_2820970677
pubmed_primary_37251909
crossref_primary_10_1016_j_heliyon_2023_e15991
crossref_citationtrail_10_1016_j_heliyon_2023_e15991
elsevier_sciencedirect_doi_10_1016_j_heliyon_2023_e15991
PublicationCentury 2000
PublicationDate 2023-05-01
PublicationDateYYYYMMDD 2023-05-01
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-05-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Heliyon
PublicationTitleAlternate Heliyon
PublicationYear 2023
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Mallick (bib45) 2015; 221
Sahebi-Fakhrabad, Sadeghi, Handfield (bib5) 2023; 11
Alizadeh-Fanalou (bib24) 2021; 141
Yeh (bib70) 2018; 78
Raglan (bib131) 2019; 145
Lyons (bib78) 2019; 28
Zhao (bib113) 2021; 20
Behl (bib16) 2020; 21
Petejova, Martinek (bib139) 2016; 160
Haffner (bib147) 2021; 18
Gheytanchi (bib23) 2023; 23
Zhao (bib54) 2012; 33
Yu (bib90) 2016; 16
Zhang (bib91) 2014; 25
Bartel (bib7) 2004; 116
Sung (bib4) 2021; 71
Lai (bib165) 2012; 33
Wang (bib148) 2018; 32
Ji (bib143) 2019; 17
Malhotra (bib40) 2016; 48
Huang (bib98) 2021; 160
Zhao (bib31) 2017; 16
Javanmardi (bib161) 2017; 16
Chen (bib99) 2017; 108
Tian (bib129) 2011; 286
Debakey (bib38) 1999; 1
Chen (bib34) 2015; 116
Fan (bib109) 2018; 23
Subramanyam (bib30) 2011; 29
Alizadeh-Fanalou (bib15) 2021; 40
Siegel, Miller, Jemal (bib41) 2016; 66
Guan (bib137) 2017; 624
Li (bib124) 2021; 11
Wang (bib174) 2021; 24
Wu (bib67) 2014; 14
Goodarzi (bib58) 2019; 6
Valle (bib95) 2021; 397
Mallick (bib167) 2015; 221
Voorhoeve (bib154) 2007; 604
Mele, Reid, Huddart (bib153) 2021; 10
Wang (bib46) 2017; 6
Tang (bib52) 2016; 108
Fabian, Sonenberg, Filipowicz (bib10) 2010; 79
Corté (bib87) 2012; 44
Li (bib116) 2021; 54
Lee, Dutta (bib14) 2009; 4
Bray (bib102) 2018; 68
Wöckel (bib105) 2018; 78
Belair (bib85) 2011; 2
Pernar (bib144) 2018; 8
Wang (bib93) 2018; 12
Waks, Winer (bib106) 2019; 321
Ding (bib141) 2021; 14
Voorhoeve (bib26) 2006; 124
Li (bib163) 2017; 108
Zhou (bib83) 2013; 42
Moradi (bib48) 2020; 66
Wu, Li, Pan (bib49) 2018; 15
Yasukawa (bib27) 2020; 295
Czarnecka (bib114) 2020; 12
Schetter, Okayama, Harris (bib88) 2012; 18
Ganju (bib160) 2017; 22
Peng (bib89) 2019; 23
Syring (bib156) 2015; 193
Yeh (bib37) 2015; 6
Bedell (bib126) 2020; 8
Yeh (bib72) 2014; 74
Merriel, Funston, Hamilton (bib145) 2018; 35
Yang, Liu (bib107) 2020; 2020
Moore, Brewer (bib132) 2017; 37
Jorge (bib20) 2021; 19
He (bib175) 2020; 11
Sadykova (bib112) 2020; 38
Gao (bib118) 2020; 12
Mahabady (bib6) 2022; 237
Sun, Gao (bib47) 2018; 18
Saginala (bib122) 2020; 8
Zhou (bib96) 2017; 16
Wu (bib59) 2015; 15
Soliman (bib173) 2021; 21
Gu (bib33) 2013; 375
Sun, Gao (bib166) 2018; 18
Fankhauser, Mostafid (bib121) 2018; 28
Wang (bib75) 2019; 58
Tran (bib29) 2016; 34
Chen (bib50) 2019; 394
Soliman (bib60) 2021; 21
Alkhayyat (bib94) 2021; 10
Vasudevan, Tong, Steitz (bib9) 2007; 318
Fan (bib176) 2020; 521
Li (bib119) 2020; 26
Nazarizadeh (bib120) 2020; 13
Sethi (bib69) 2014; 50
Wong (bib123) 2021; 13
Staedel (bib84) 2015; 4
Di Tucci (bib130) 2019; 30
Damjanov (bib152) 2021; 50
Torre (bib136) 2018; 68
Shu (bib158) 2015; 9
Liu, Sall, Yang (bib13) 2008; 9
Wang (bib66) 2017; 8
Wang (bib65) 2010; 38
(bib155) 2013; 52
Wu (bib172) 2014; 14
Shaker (bib62) 2020; 9
Yeh (bib71) 2020; 10
Ghasemi, Mozdarani (bib82) 2015; 32
Momenimovahed (bib135) 2019; 11
Liu (bib74) 2014; 74
Kong (bib149) 2016; 35
Moradi (bib36) 2018; 64
Dalmay, Edwards (bib22) 2006; 25
Ragusa (bib92) 2012; 90
Volinia (bib79) 2006; 103
McGlynn, London (bib57) 2005; 19
Bray (bib3) 2021; 127
Harrison (bib110) 2018; 18
Humphrey (bib146) 2017; 7
Wang (bib56) 2019; 8
Yu (bib100) 2012; 18
Shan (bib28) 2020; 19
Jabbari (bib164) 2018; 46
Dela Cruz, Tanoue, Matthay (bib42) 2011; 32
Jiao, Wang, Wang (bib64) 2018; 22
Siegel (bib2) 2021; 71
Cho (bib81) 2009; 28
Ambros (bib8) 2001; 107
Fan (bib61) 2020; 521
Wroblewski, Peek (bib77) 2016; 908
Arnold (bib76) 2020; 159
Calin, Croce (bib1) 2006; 6
Shingarev, Jaimes (bib138) 2017; 313
Wang (bib68) 2021; 24
Ma, Hui, Chan (bib51) 2017; 26
Eaton (bib111) 2021; 68
Singla (bib151) 2019; 29
Liu (bib125) 2020; 39
Liu (bib134) 2016; 7
Alizadeh-Fanalou (bib17) 2020; 44
Ghaffari (bib18) 2022; 28
Yamashita (bib32) 2012; 82
Wang (bib169) 2019; 8
Tavakoli (bib19) 2021; 23
Lee, Feinbaum, Ambros (bib11) 1993; 75
Pfister (bib25) 2009; 117
Perazella, Dreicer, Rosner (bib140) 2018; 94
Tu (bib73) 2015; 125
Wang (bib159) 2019; 12
Lai (bib44) 2012; 33
Xia (bib35) 2019; 23
Siegel, Miller, Jemal (bib103) 2020; 70
Urick, Bell (bib133) 2019; 19
Cao, Feng, Chen (bib150) 2017; 120
Xu, Xu, Gao (bib117) 2018; 22
Momenimovahed, Salehiniya (bib104) 2019; 11
Wang (bib168) 2017; 6
Wang (bib171) 2010; 38
Lee (bib162) 2017; 25
Sheng (bib115) 2021; 11
Iman (bib157) 2016; 11
DeSantis (bib101) 2019; 69
Necula (bib80) 2019; 25
Zhang (bib21) 2007; 302
de Groot (bib43) 2018; 7
Mizrahi (bib97) 2020; 395
Wightman, Ha, Ruvkun (bib12) 1993; 75
Chua (bib53) 2003; 98
Revathidevi (bib128) 2021; 496
Li (bib63) 2019; 19
Tan, Tan, Gan (bib170) 2014; 36
Tan, Tan, Gan (bib55) 2014; 36
Vo (bib86) 2014; 9
Huang (bib142) 2015; 48
Arnold (bib39) 2015; 64
Eun, Perkins (bib127) 2020; 104
Cheng, Chen, Huang (bib108) 2018; 15
Cao (10.1016/j.heliyon.2023.e15991_bib150) 2017; 120
Malhotra (10.1016/j.heliyon.2023.e15991_bib40) 2016; 48
Shu (10.1016/j.heliyon.2023.e15991_bib158) 2015; 9
Wang (10.1016/j.heliyon.2023.e15991_bib168) 2017; 6
Sahebi-Fakhrabad (10.1016/j.heliyon.2023.e15991_bib5) 2023; 11
Volinia (10.1016/j.heliyon.2023.e15991_bib79) 2006; 103
Lyons (10.1016/j.heliyon.2023.e15991_bib78) 2019; 28
Wong (10.1016/j.heliyon.2023.e15991_bib123) 2021; 13
Bedell (10.1016/j.heliyon.2023.e15991_bib126) 2020; 8
Chua (10.1016/j.heliyon.2023.e15991_bib53) 2003; 98
Staedel (10.1016/j.heliyon.2023.e15991_bib84) 2015; 4
Wang (10.1016/j.heliyon.2023.e15991_bib93) 2018; 12
Yang (10.1016/j.heliyon.2023.e15991_bib107) 2020; 2020
Alkhayyat (10.1016/j.heliyon.2023.e15991_bib94) 2021; 10
Xia (10.1016/j.heliyon.2023.e15991_bib35) 2019; 23
Soliman (10.1016/j.heliyon.2023.e15991_bib60) 2021; 21
Arnold (10.1016/j.heliyon.2023.e15991_bib76) 2020; 159
Voorhoeve (10.1016/j.heliyon.2023.e15991_bib154) 2007; 604
Valle (10.1016/j.heliyon.2023.e15991_bib95) 2021; 397
Tu (10.1016/j.heliyon.2023.e15991_bib73) 2015; 125
Merriel (10.1016/j.heliyon.2023.e15991_bib145) 2018; 35
DeSantis (10.1016/j.heliyon.2023.e15991_bib101) 2019; 69
Wang (10.1016/j.heliyon.2023.e15991_bib159) 2019; 12
Wu (10.1016/j.heliyon.2023.e15991_bib172) 2014; 14
Belair (10.1016/j.heliyon.2023.e15991_bib85) 2011; 2
Li (10.1016/j.heliyon.2023.e15991_bib124) 2021; 11
(10.1016/j.heliyon.2023.e15991_bib155) 2013; 52
Fan (10.1016/j.heliyon.2023.e15991_bib176) 2020; 521
Wightman (10.1016/j.heliyon.2023.e15991_bib12) 1993; 75
Necula (10.1016/j.heliyon.2023.e15991_bib80) 2019; 25
Chen (10.1016/j.heliyon.2023.e15991_bib99) 2017; 108
Fabian (10.1016/j.heliyon.2023.e15991_bib10) 2010; 79
Yu (10.1016/j.heliyon.2023.e15991_bib90) 2016; 16
Lai (10.1016/j.heliyon.2023.e15991_bib165) 2012; 33
Saginala (10.1016/j.heliyon.2023.e15991_bib122) 2020; 8
Jorge (10.1016/j.heliyon.2023.e15991_bib20) 2021; 19
Zhao (10.1016/j.heliyon.2023.e15991_bib54) 2012; 33
Li (10.1016/j.heliyon.2023.e15991_bib63) 2019; 19
Nazarizadeh (10.1016/j.heliyon.2023.e15991_bib120) 2020; 13
Wu (10.1016/j.heliyon.2023.e15991_bib59) 2015; 15
Chen (10.1016/j.heliyon.2023.e15991_bib34) 2015; 116
Momenimovahed (10.1016/j.heliyon.2023.e15991_bib104) 2019; 11
Tang (10.1016/j.heliyon.2023.e15991_bib52) 2016; 108
Fan (10.1016/j.heliyon.2023.e15991_bib61) 2020; 521
Zhao (10.1016/j.heliyon.2023.e15991_bib31) 2017; 16
Sun (10.1016/j.heliyon.2023.e15991_bib47) 2018; 18
Pernar (10.1016/j.heliyon.2023.e15991_bib144) 2018; 8
Arnold (10.1016/j.heliyon.2023.e15991_bib39) 2015; 64
Wang (10.1016/j.heliyon.2023.e15991_bib68) 2021; 24
Kong (10.1016/j.heliyon.2023.e15991_bib149) 2016; 35
Tan (10.1016/j.heliyon.2023.e15991_bib55) 2014; 36
Zhao (10.1016/j.heliyon.2023.e15991_bib113) 2021; 20
Subramanyam (10.1016/j.heliyon.2023.e15991_bib30) 2011; 29
Mizrahi (10.1016/j.heliyon.2023.e15991_bib97) 2020; 395
Sung (10.1016/j.heliyon.2023.e15991_bib4) 2021; 71
Yamashita (10.1016/j.heliyon.2023.e15991_bib32) 2012; 82
Eaton (10.1016/j.heliyon.2023.e15991_bib111) 2021; 68
Shan (10.1016/j.heliyon.2023.e15991_bib28) 2020; 19
Wang (10.1016/j.heliyon.2023.e15991_bib46) 2017; 6
Schetter (10.1016/j.heliyon.2023.e15991_bib88) 2012; 18
Voorhoeve (10.1016/j.heliyon.2023.e15991_bib26) 2006; 124
Vo (10.1016/j.heliyon.2023.e15991_bib86) 2014; 9
Siegel (10.1016/j.heliyon.2023.e15991_bib103) 2020; 70
Ganju (10.1016/j.heliyon.2023.e15991_bib160) 2017; 22
Alizadeh-Fanalou (10.1016/j.heliyon.2023.e15991_bib17) 2020; 44
Haffner (10.1016/j.heliyon.2023.e15991_bib147) 2021; 18
Soliman (10.1016/j.heliyon.2023.e15991_bib173) 2021; 21
Fan (10.1016/j.heliyon.2023.e15991_bib109) 2018; 23
Revathidevi (10.1016/j.heliyon.2023.e15991_bib128) 2021; 496
Ding (10.1016/j.heliyon.2023.e15991_bib141) 2021; 14
Wang (10.1016/j.heliyon.2023.e15991_bib148) 2018; 32
Yasukawa (10.1016/j.heliyon.2023.e15991_bib27) 2020; 295
Cho (10.1016/j.heliyon.2023.e15991_bib81) 2009; 28
Petejova (10.1016/j.heliyon.2023.e15991_bib139) 2016; 160
Momenimovahed (10.1016/j.heliyon.2023.e15991_bib135) 2019; 11
Sun (10.1016/j.heliyon.2023.e15991_bib166) 2018; 18
Guan (10.1016/j.heliyon.2023.e15991_bib137) 2017; 624
Jabbari (10.1016/j.heliyon.2023.e15991_bib164) 2018; 46
Shaker (10.1016/j.heliyon.2023.e15991_bib62) 2020; 9
Zhou (10.1016/j.heliyon.2023.e15991_bib96) 2017; 16
Wroblewski (10.1016/j.heliyon.2023.e15991_bib77) 2016; 908
Liu (10.1016/j.heliyon.2023.e15991_bib134) 2016; 7
Gao (10.1016/j.heliyon.2023.e15991_bib118) 2020; 12
Li (10.1016/j.heliyon.2023.e15991_bib119) 2020; 26
Zhou (10.1016/j.heliyon.2023.e15991_bib83) 2013; 42
Li (10.1016/j.heliyon.2023.e15991_bib116) 2021; 54
Huang (10.1016/j.heliyon.2023.e15991_bib142) 2015; 48
Bray (10.1016/j.heliyon.2023.e15991_bib3) 2021; 127
Mallick (10.1016/j.heliyon.2023.e15991_bib45) 2015; 221
Torre (10.1016/j.heliyon.2023.e15991_bib136) 2018; 68
Moradi (10.1016/j.heliyon.2023.e15991_bib36) 2018; 64
Wang (10.1016/j.heliyon.2023.e15991_bib174) 2021; 24
Yeh (10.1016/j.heliyon.2023.e15991_bib37) 2015; 6
Siegel (10.1016/j.heliyon.2023.e15991_bib41) 2016; 66
Zhang (10.1016/j.heliyon.2023.e15991_bib91) 2014; 25
Jiao (10.1016/j.heliyon.2023.e15991_bib64) 2018; 22
Peng (10.1016/j.heliyon.2023.e15991_bib89) 2019; 23
Xu (10.1016/j.heliyon.2023.e15991_bib117) 2018; 22
Sethi (10.1016/j.heliyon.2023.e15991_bib69) 2014; 50
Siegel (10.1016/j.heliyon.2023.e15991_bib2) 2021; 71
Bartel (10.1016/j.heliyon.2023.e15991_bib7) 2004; 116
Liu (10.1016/j.heliyon.2023.e15991_bib13) 2008; 9
Chen (10.1016/j.heliyon.2023.e15991_bib50) 2019; 394
Tran (10.1016/j.heliyon.2023.e15991_bib29) 2016; 34
Wu (10.1016/j.heliyon.2023.e15991_bib49) 2018; 15
Shingarev (10.1016/j.heliyon.2023.e15991_bib138) 2017; 313
Li (10.1016/j.heliyon.2023.e15991_bib163) 2017; 108
Wang (10.1016/j.heliyon.2023.e15991_bib169) 2019; 8
Huang (10.1016/j.heliyon.2023.e15991_bib98) 2021; 160
Zhang (10.1016/j.heliyon.2023.e15991_bib21) 2007; 302
Tavakoli (10.1016/j.heliyon.2023.e15991_bib19) 2021; 23
Dela Cruz (10.1016/j.heliyon.2023.e15991_bib42) 2011; 32
de Groot (10.1016/j.heliyon.2023.e15991_bib43) 2018; 7
Goodarzi (10.1016/j.heliyon.2023.e15991_bib58) 2019; 6
Sheng (10.1016/j.heliyon.2023.e15991_bib115) 2021; 11
Mahabady (10.1016/j.heliyon.2023.e15991_bib6) 2022; 237
Fankhauser (10.1016/j.heliyon.2023.e15991_bib121) 2018; 28
Ji (10.1016/j.heliyon.2023.e15991_bib143) 2019; 17
Debakey (10.1016/j.heliyon.2023.e15991_bib38) 1999; 1
Corté (10.1016/j.heliyon.2023.e15991_bib87) 2012; 44
Lee (10.1016/j.heliyon.2023.e15991_bib11) 1993; 75
Wang (10.1016/j.heliyon.2023.e15991_bib171) 2010; 38
Damjanov (10.1016/j.heliyon.2023.e15991_bib152) 2021; 50
Syring (10.1016/j.heliyon.2023.e15991_bib156) 2015; 193
Behl (10.1016/j.heliyon.2023.e15991_bib16) 2020; 21
Tian (10.1016/j.heliyon.2023.e15991_bib129) 2011; 286
Javanmardi (10.1016/j.heliyon.2023.e15991_bib161) 2017; 16
Iman (10.1016/j.heliyon.2023.e15991_bib157) 2016; 11
Gheytanchi (10.1016/j.heliyon.2023.e15991_bib23) 2023; 23
Yeh (10.1016/j.heliyon.2023.e15991_bib72) 2014; 74
Di Tucci (10.1016/j.heliyon.2023.e15991_bib130) 2019; 30
Tan (10.1016/j.heliyon.2023.e15991_bib170) 2014; 36
Moradi (10.1016/j.heliyon.2023.e15991_bib48) 2020; 66
Vasudevan (10.1016/j.heliyon.2023.e15991_bib9) 2007; 318
Urick (10.1016/j.heliyon.2023.e15991_bib133) 2019; 19
Perazella (10.1016/j.heliyon.2023.e15991_bib140) 2018; 94
Wang (10.1016/j.heliyon.2023.e15991_bib65) 2010; 38
Eun (10.1016/j.heliyon.2023.e15991_bib127) 2020; 104
Gu (10.1016/j.heliyon.2023.e15991_bib33) 2013; 375
Mallick (10.1016/j.heliyon.2023.e15991_bib167) 2015; 221
Ghaffari (10.1016/j.heliyon.2023.e15991_bib18) 2022; 28
Lai (10.1016/j.heliyon.2023.e15991_bib44) 2012; 33
Ambros (10.1016/j.heliyon.2023.e15991_bib8) 2001; 107
Alizadeh-Fanalou (10.1016/j.heliyon.2023.e15991_bib24) 2021; 141
He (10.1016/j.heliyon.2023.e15991_bib175) 2020; 11
Yeh (10.1016/j.heliyon.2023.e15991_bib70) 2018; 78
Mele (10.1016/j.heliyon.2023.e15991_bib153) 2021; 10
Yeh (10.1016/j.heliyon.2023.e15991_bib71) 2020; 10
Wu (10.1016/j.heliyon.2023.e15991_bib67) 2014; 14
Raglan (10.1016/j.heliyon.2023.e15991_bib131) 2019; 145
Dalmay (10.1016/j.heliyon.2023.e15991_bib22) 2006; 25
Liu (10.1016/j.heliyon.2023.e15991_bib125) 2020; 39
Ragusa (10.1016/j.heliyon.2023.e15991_bib92) 2012; 90
Czarnecka (10.1016/j.heliyon.2023.e15991_bib114) 2020; 12
Wöckel (10.1016/j.heliyon.2023.e15991_bib105) 2018; 78
Liu (10.1016/j.heliyon.2023.e15991_bib74) 2014; 74
Alizadeh-Fanalou (10.1016/j.heliyon.2023.e15991_bib15) 2021; 40
Ma (10.1016/j.heliyon.2023.e15991_bib51) 2017; 26
Bray (10.1016/j.heliyon.2023.e15991_bib102) 2018; 68
Lee (10.1016/j.heliyon.2023.e15991_bib162) 2017; 25
Cheng (10.1016/j.heliyon.2023.e15991_bib108) 2018; 15
Humphrey (10.1016/j.heliyon.2023.e15991_bib146) 2017; 7
Wang (10.1016/j.heliyon.2023.e15991_bib75) 2019; 58
Lee (10.1016/j.heliyon.2023.e15991_bib14) 2009; 4
Pfister (10.1016/j.heliyon.2023.e15991_bib25) 2009; 117
Wang (10.1016/j.heliyon.2023.e15991_bib56) 2019; 8
Calin (10.1016/j.heliyon.2023.e15991_bib1) 2006; 6
McGlynn (10.1016/j.heliyon.2023.e15991_bib57) 2005; 19
Ghasemi (10.1016/j.heliyon.2023.e15991_bib82) 2015; 32
Harrison (10.1016/j.heliyon.2023.e15991_bib110) 2018; 18
Wang (10.1016/j.heliyon.2023.e15991_bib66) 2017; 8
Yu (10.1016/j.heliyon.2023.e15991_bib100) 2012; 18
Sadykova (10.1016/j.heliyon.2023.e15991_bib112) 2020; 38
Moore (10.1016/j.heliyon.2023.e15991_bib132) 2017; 37
Waks (10.1016/j.heliyon.2023.e15991_bib106) 2019; 321
Singla (10.1016/j.heliyon.2023.e15991_bib151) 2019; 29
References_xml – volume: 64
  start-page: 847
  year: 2018
  end-page: 854
  ident: bib36
  article-title: Lower expression of miR-10a in coronary artery disease and its association with pro/anti-inflammatory cytokines
  publication-title: Clin. Lab.
– volume: 12
  start-page: 55
  year: 2019
  ident: bib159
  article-title: Noncoding RNAs in cancer therapy resistance and targeted drug development
  publication-title: J. Hematol. Oncol.
– volume: 14
  start-page: 1
  year: 2014
  end-page: 11
  ident: bib172
  article-title: miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis
  publication-title: BMC Cancer
– volume: 521
  start-page: 196
  year: 2020
  end-page: 203
  ident: bib176
  article-title: lncRNA OSER1-AS1 acts as a ceRNA to promote tumorigenesis in hepatocellular carcinoma by regulating miR-372-3p/Rab23 axis
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 19
  start-page: eRB5996
  year: 2021
  ident: bib20
  article-title: MicroRNAs: understanding their role in gene expression and cancer
  publication-title: Einstein (Sao Paulo)
– volume: 33
  start-page: 675
  year: 2012
  end-page: 688
  ident: bib165
  article-title: Comparative proteomic profiling of human lung adenocarcinoma cells (CL 1–0) expressing miR‐372
  publication-title: Electrophoresis
– volume: 9
  start-page: 230
  year: 2020
  end-page: 240
  ident: bib62
  article-title: Long non-coding HULC and miRNA-372 as diagnostic biomarkers in hepatocellular carcinoma
  publication-title: Rep. Biochem. Mol. Biol.
– volume: 18
  start-page: 39
  year: 2018
  end-page: 50
  ident: bib110
  article-title: Current and future therapeutic approaches for osteosarcoma
  publication-title: Expert Rev. Anticancer Ther.
– volume: 70
  start-page: 7
  year: 2020
  end-page: 30
  ident: bib103
  article-title: Cancer statistics
  publication-title: CA A Cancer J. Clin.
– volume: 624
  start-page: 14
  year: 2017
  end-page: 20
  ident: bib137
  article-title: The role of miR-372 in ovarian carcinoma cell proliferation
  publication-title: Gene
– volume: 13
  start-page: 6603
  year: 2020
  end-page: 6615
  ident: bib120
  article-title: MicroRNA-154: a novel candidate for diagnosis and therapy of human cancers
  publication-title: OncoTargets Ther.
– volume: 22
  start-page: 2598
  year: 2018
  end-page: 2605
  ident: bib64
  article-title: MicroRNA-16 suppressed the invasion and migration of osteosarcoma by directly inhibiting RAB23
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 4
  start-page: e246
  year: 2015
  ident: bib84
  article-title: Inhibition of gastric tumor cell growth using seed-targeting LNA as specific, long-lasting MicroRNA inhibitors
  publication-title: Mol. Ther. Nucleic Acids
– volume: 141
  year: 2021
  ident: bib24
  article-title: Dual role of microRNA-1297 in the suppression and progression of human malignancies
  publication-title: Biomed. Pharmacother.
– volume: 908
  start-page: 393
  year: 2016
  end-page: 408
  ident: bib77
  article-title: Helicobacter pylori, cancer, and the gastric microbiota
  publication-title: Adv. Exp. Med. Biol.
– volume: 11
  year: 2021
  ident: bib124
  article-title: Frontiers in bladder cancer genomic research
  publication-title: Front. Oncol.
– volume: 521
  start-page: 196
  year: 2020
  end-page: 203
  ident: bib61
  article-title: lncRNA OSER1-AS1 acts as a ceRNA to promote tumorigenesis in hepatocellular carcinoma by regulating miR-372-3p/Rab23 axis
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 108
  start-page: 1493
  year: 2017
  end-page: 1503
  ident: bib163
  article-title: Co‐delivery of micro RNA‐21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy
  publication-title: Cancer Sci.
– volume: 38
  start-page: 5366
  year: 2010
  end-page: 5383
  ident: bib171
  article-title: CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer
  publication-title: Nucleic Acids Res.
– volume: 24
  start-page: 449
  year: 2021
  end-page: 461
  ident: bib68
  article-title: Effects of FER1L4-miR-106a-5p/miR-372-5p-E2F1 regulatory axis on drug resistance in liver cancer chemotherapy
  publication-title: Mol. Ther. Nucleic Acids
– volume: 26
  start-page: 677
  year: 2017
  end-page: 685
  ident: bib51
  article-title: Investigational drugs for nasopharyngeal carcinoma
  publication-title: Expet Opin. Invest. Drugs
– volume: 58
  start-page: 35
  year: 2019
  end-page: 41
  ident: bib75
  article-title: MEHP promotes the proliferation of oral cancer cells via down regulation of miR-27b-5p and miR-372-5p
  publication-title: Toxicol. Vitro
– volume: 14
  start-page: 107
  year: 2014
  ident: bib67
  article-title: miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis
  publication-title: BMC Cancer
– volume: 159
  start-page: 335
  year: 2020
  end-page: 349.e15
  ident: bib76
  article-title: Global burden of 5 major types of gastrointestinal cancer
  publication-title: Gastroenterology
– volume: 237
  start-page: 2309
  year: 2022
  end-page: 2344
  ident: bib6
  article-title: Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: mechanisms of initiation, progression, and drug sensitivity
  publication-title: J. Cell. Physiol.
– volume: 23
  start-page: 10
  year: 2023
  ident: bib23
  article-title: Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis
  publication-title: Cancer Cell Int.
– volume: 120
  start-page: 256
  year: 2017
  end-page: 263
  ident: bib150
  article-title: Repression of MicroRNA-372 by arsenic sulphide inhibits prostate cancer cell proliferation and migration through regulation of large tumour suppressor kinase 2
  publication-title: Basic Clin. Pharmacol. Toxicol.
– volume: 69
  start-page: 438
  year: 2019
  end-page: 451
  ident: bib101
  article-title: Breast cancer statistics
  publication-title: CA A Cancer J. Clin.
– volume: 68
  start-page: 284
  year: 2018
  end-page: 296
  ident: bib136
  article-title: Ovarian cancer statistics
  publication-title: CA A Cancer J. Clin.
– volume: 8
  start-page: 712
  year: 2019
  end-page: 728
  ident: bib56
  article-title: MicroRNA-372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK-dependent p53 signaling pathway
  publication-title: Cancer Med.
– volume: 74
  year: 2014
  ident: bib72
  article-title: Hypoxia-induced miR-372 targets p62 to affect the progression of oral carcinoma
  publication-title: Cancer Res.
– volume: 16
  start-page: 8069
  year: 2017
  end-page: 8075
  ident: bib31
  article-title: microRNA-372 inhibits proliferation and induces apoptosis in human breast cancer cells by directly targeting E2F1
  publication-title: Mol. Med. Rep.
– volume: 28
  start-page: 88
  year: 2018
  end-page: 92
  ident: bib121
  article-title: Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle
  publication-title: Curr. Opin. Urol.
– volume: 12
  start-page: 8287
  year: 2020
  end-page: 8302
  ident: bib118
  article-title: CircRNA Circ_0001721 promotes the progression of osteosarcoma through miR-372-3p/MAPK7 Axis
  publication-title: Cancer Manag. Res.
– volume: 44
  year: 2020
  ident: bib17
  article-title: Dysregulation of microRNAs regulating survivin in CD4+ T cells in multiple sclerosis
  publication-title: Mult. Scler. Relat. Disord.
– volume: 6
  start-page: 12
  year: 2019
  ident: bib58
  article-title: Global incidence and mortality of liver cancers and its relationship with the human development index (HDI): an ecology study in 2018
  publication-title: World Cancer Res J
– volume: 15
  start-page: 182
  year: 2015
  ident: bib59
  article-title: Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma
  publication-title: BMC Cancer
– volume: 19
  start-page: 1
  year: 2019
  end-page: 11
  ident: bib63
  article-title: Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p
  publication-title: Cancer Cell Int.
– volume: 13
  year: 2021
  ident: bib123
  article-title: Imaging and management of bladder cancer
  publication-title: Cancers
– volume: 295
  start-page: 444
  year: 2020
  end-page: 457
  ident: bib27
  article-title: The microRNAs miR-302b and miR-372 regulate mitochondrial metabolism via the SLC25A12 transporter, which controls MAVS-mediated antiviral innate immunity
  publication-title: J. Biol. Chem.
– volume: 25
  start-page: 2029
  year: 2019
  end-page: 2044
  ident: bib80
  article-title: Recent advances in gastric cancer early diagnosis
  publication-title: World J. Gastroenterol.
– volume: 66
  year: 2020
  ident: bib48
  article-title: Emerging role of miR-372 and miR-101a in head and neck squamous cell carcinoma
  publication-title: Clin. Lab.
– volume: 9
  start-page: 711
  year: 2014
  end-page: 721
  ident: bib86
  article-title: Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules
  publication-title: ACS Chem. Biol.
– volume: 36
  start-page: 170
  year: 2014
  end-page: 173
  ident: bib55
  article-title: Elucidating the roles of miR-372 in cell proliferation and apoptosis of nasopharyngeal carcinoma TW01 cells
  publication-title: Exp. Oncol.
– volume: 23
  start-page: 3224
  year: 2019
  end-page: 3233
  ident: bib35
  article-title: FER1L4/miR-372/E2F1 works as a ceRNA system to regulate the proliferation and cell cycle of glioma cells
  publication-title: J. Cell Mol. Med.
– volume: 68
  start-page: 394
  year: 2018
  end-page: 424
  ident: bib102
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA A Cancer J. Clin.
– volume: 12
  year: 2020
  ident: bib114
  article-title: Molecular biology of osteosarcoma
  publication-title: Cancers
– volume: 64
  start-page: 381
  year: 2015
  end-page: 387
  ident: bib39
  article-title: Global incidence of oesophageal cancer by histological subtype in 2012
  publication-title: Gut
– volume: 25
  start-page: 346
  year: 2014
  end-page: 352
  ident: bib91
  article-title: Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy
  publication-title: Anti Cancer Drugs
– volume: 6
  start-page: 6062
  year: 2015
  end-page: 6075
  ident: bib37
  article-title: miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo
  publication-title: Oncotarget
– volume: 395
  start-page: 2008
  year: 2020
  end-page: 2020
  ident: bib97
  article-title: Pancreatic cancer
  publication-title: Lancet
– volume: 18
  start-page: 79
  year: 2021
  end-page: 92
  ident: bib147
  article-title: Genomic and phenotypic heterogeneity in prostate cancer
  publication-title: Nat. Rev. Urol.
– volume: 18
  start-page: 1252
  year: 2018
  ident: bib47
  article-title: Propofol suppresses growth, migration and invasion of A549 cells by down-regulation of miR-372
  publication-title: BMC Cancer
– volume: 103
  start-page: 2257
  year: 2006
  end-page: 2261
  ident: bib79
  article-title: A microRNA expression signature of human solid tumors defines cancer gene targets
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 22
  start-page: 424
  year: 2017
  end-page: 432
  ident: bib160
  article-title: miRNA nanotherapeutics for cancer
  publication-title: Drug Discov. Today
– volume: 71
  start-page: 7
  year: 2021
  end-page: 33
  ident: bib2
  article-title: Cancer statistics, 2021
  publication-title: CA A Cancer J. Clin.
– volume: 32
  year: 2015
  ident: bib82
  article-title: The Effect of miR-372 on genome instability in MKN-45 cell line
  publication-title: J. Isfahan Med. School
– volume: 17
  start-page: 2400
  year: 2019
  end-page: 2408
  ident: bib143
  article-title: MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting ATAD2 in renal cell carcinoma
  publication-title: Oncol. Lett.
– volume: 145
  start-page: 1719
  year: 2019
  end-page: 1730
  ident: bib131
  article-title: Risk factors for endometrial cancer: an umbrella review of the literature
  publication-title: Int. J. Cancer
– volume: 302
  start-page: 1
  year: 2007
  end-page: 12
  ident: bib21
  article-title: microRNAs as oncogenes and tumor suppressors
  publication-title: Dev. Biol.
– volume: 18
  start-page: 244
  year: 2012
  end-page: 252
  ident: bib88
  article-title: The role of microRNAs in colorectal cancer
  publication-title: Cancer J.
– volume: 108
  start-page: 1811
  year: 2017
  end-page: 1819
  ident: bib99
  article-title: Downregulation of ULK1 by microRNA-372 inhibits the survival of human pancreatic adenocarcinoma cells
  publication-title: Cancer Sci.
– volume: 15
  start-page: 2812
  year: 2018
  end-page: 2817
  ident: bib108
  article-title: miR-372 promotes breast cancer cell proliferation by directly targeting LATS2
  publication-title: Exp. Ther. Med.
– volume: 25
  start-page: 1544
  year: 2017
  end-page: 1555
  ident: bib162
  article-title: RNA nanoparticle-based targeted therapy for glioblastoma through inhibition of oncogenic miR-21
  publication-title: Mol. Ther.
– volume: 74
  year: 2014
  ident: bib74
  article-title: Upregulation of microRNA-372 & 373 associates with cervical lymph node metastasis and poor prognosis of oral carcinomas
  publication-title: Cancer Res.
– volume: 10
  start-page: 25
  year: 2021
  ident: bib94
  article-title: Epidemiology of gallbladder cancer in the Unites States: a population-based study
  publication-title: Chin. Clin. Oncol.
– volume: 94
  start-page: 471
  year: 2018
  end-page: 483
  ident: bib140
  article-title: Renal cell carcinoma for the nephrologist
  publication-title: Kidney Int.
– volume: 24
  start-page: 449
  year: 2021
  end-page: 461
  ident: bib174
  article-title: Effects of FER1L4-miR-106a-5p/miR-372-5p-E2F1 regulatory axis on drug resistance in liver cancer chemotherapy
  publication-title: Mol. Ther. Nucleic Acids
– volume: 75
  start-page: 843
  year: 1993
  end-page: 854
  ident: bib11
  article-title: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
  publication-title: Cell
– volume: 28
  start-page: 1367
  year: 2022
  end-page: 1372
  ident: bib18
  article-title: Captopril and spironolactone can attenuate diabetic nephropathy in wistar rats by targeting ABCA1 and microRNA-33
  publication-title: Curr. Pharmaceut. Des.
– volume: 116
  start-page: 225
  year: 2015
  end-page: 232
  ident: bib34
  article-title: miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2
  publication-title: J. Cell. Biochem.
– volume: 66
  start-page: 7
  year: 2016
  end-page: 30
  ident: bib41
  article-title: Cancer statistics
  publication-title: CA A Cancer J. Clin.
– volume: 12
  start-page: 1949
  year: 2018
  end-page: 1964
  ident: bib93
  article-title: miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways
  publication-title: Mol. Oncol.
– volume: 321
  start-page: 288
  year: 2019
  end-page: 300
  ident: bib106
  article-title: Breast cancer treatment: a review
  publication-title: JAMA
– volume: 35
  start-page: 828
  year: 2016
  end-page: 835
  ident: bib149
  article-title: microRNA-372 suppresses migration and invasion by targeting p65 in human prostate cancer cells
  publication-title: DNA Cell Biol.
– volume: 46
  start-page: 364
  year: 2018
  end-page: 372
  ident: bib164
  article-title: Assessment of synergistic effect of combining hyperthermia with irradiation and calcium carbonate nanoparticles on proliferation of human breast adenocarcinoma cell line (MCF-7 cells)
  publication-title: Artif. Cells, Nanomed. Biotechnol.
– volume: 4
  start-page: 199
  year: 2009
  end-page: 227
  ident: bib14
  article-title: MicroRNAs in cancer
  publication-title: Annu. Rev. Pathol.
– volume: 37
  start-page: 435
  year: 2017
  end-page: 442
  ident: bib132
  article-title: Endometrial cancer: is this a new disease?
  publication-title: Am. Soc. Clin. Oncol. Educ. Book
– volume: 28
  start-page: 397
  year: 2019
  end-page: 412
  ident: bib78
  article-title: Gastric cancer: epidemiology, biology, and prevention: a mini review
  publication-title: Eur. J. Cancer Prev.
– volume: 90
  start-page: 1421
  year: 2012
  end-page: 1438
  ident: bib92
  article-title: Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors
  publication-title: J. Mol. Med. (Berl.)
– volume: 10
  start-page: 47
  year: 2020
  ident: bib71
  article-title: The miR-372-ZBTB7A oncogenic Axis suppresses TRAIL-R2 associated drug sensitivity in oral carcinoma
  publication-title: Front. Oncol.
– volume: 8
  start-page: 34429
  year: 2017
  end-page: 34441
  ident: bib66
  article-title: Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372
  publication-title: Oncotarget
– volume: 11
  start-page: 151
  year: 2019
  end-page: 164
  ident: bib104
  article-title: Epidemiological characteristics of and risk factors for breast cancer in the world
  publication-title: Breast Cancer
– volume: 33
  start-page: 675
  year: 2012
  end-page: 688
  ident: bib44
  article-title: Comparative proteomic profiling of human lung adenocarcinoma cells (CL 1-0) expressing miR-372
  publication-title: Electrophoresis
– volume: 16
  start-page: 424
  year: 2016
  end-page: 431
  ident: bib90
  article-title: Serum miR-372 is a diagnostic and prognostic biomarker in patients with early colorectal cancer
  publication-title: Anti Cancer Agents Med. Chem.
– volume: 116
  start-page: 281
  year: 2004
  end-page: 297
  ident: bib7
  article-title: MicroRNAs: genomics, biogenesis, mechanism, and function
  publication-title: Cell
– volume: 19
  start-page: 3845
  year: 2020
  end-page: 3850
  ident: bib28
  article-title: Increased levels of miR-372 correlate with disease progression in patients with hyperlipidemic acute pancreatitis
  publication-title: Exp. Ther. Med.
– volume: 18
  start-page: 981
  year: 2012
  end-page: 992
  ident: bib100
  article-title: MicroRNA alterations of pancreatic intraepithelial neoplasias
  publication-title: Clin. Cancer Res.
– volume: 29
  start-page: 344
  year: 2019
  end-page: 349
  ident: bib151
  article-title: Genetics of testicular germ cell tumors
  publication-title: Curr. Opin. Urol.
– volume: 9
  start-page: 9731
  year: 2015
  end-page: 9740
  ident: bib158
  article-title: Systemic delivery of anti-miRNA for suppression of triple negative breast cancer utilizing RNA nanotechnology
  publication-title: ACS Nano
– volume: 496
  start-page: 104
  year: 2021
  end-page: 116
  ident: bib128
  article-title: APOBEC: a molecular driver in cervical cancer pathogenesis
  publication-title: Cancer Lett.
– volume: 32
  start-page: 605
  year: 2011
  end-page: 644
  ident: bib42
  article-title: Lung cancer: epidemiology, etiology, and prevention
  publication-title: Clin. Chest Med.
– volume: 11
  year: 2021
  ident: bib115
  article-title: Osteosarcoma and metastasis
  publication-title: Front. Oncol.
– volume: 604
  start-page: 17
  year: 2007
  end-page: 46
  ident: bib154
  article-title: A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors
  publication-title: Adv. Exp. Med. Biol.
– volume: 8
  year: 2020
  ident: bib122
  article-title: Epidemiology of bladder cancer
  publication-title: Med. Sci.
– volume: 1
  start-page: 106
  year: 1999
  end-page: 108
  ident: bib38
  article-title: Carcinoma of the lung and tobacco smoking: a historical perspective
  publication-title: Ochsner J.
– volume: 15
  start-page: 3687
  year: 2018
  end-page: 3692
  ident: bib49
  article-title: Nasopharyngeal carcinoma: a review of current updates
  publication-title: Exp. Ther. Med.
– volume: 48
  start-page: 889
  year: 2016
  end-page: 902
  ident: bib40
  article-title: Risk factors for lung cancer worldwide
  publication-title: Eur. Respir. J.
– volume: 6
  start-page: 1323
  year: 2017
  end-page: 1330
  ident: bib46
  article-title: MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma
  publication-title: Cancer Med.
– volume: 71
  start-page: 209
  year: 2021
  end-page: 249
  ident: bib4
  article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA A Cancer J. Clin.
– volume: 125
  start-page: E365
  year: 2015
  end-page: E370
  ident: bib73
  article-title: Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas
  publication-title: Laryngoscope
– volume: 22
  start-page: 62
  year: 2018
  end-page: 69
  ident: bib117
  article-title: MiR-372-3p inhibits the growth and metastasis of osteosarcoma cells by targeting FXYD6
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 52
  start-page: 10
  year: 2013
  end-page: 151
  ident: bib155
  article-title: Abstracts of the 65th congress of the German society for urology. September 25-28, 2013. Dresden, Germany]
  publication-title: Urologe
– volume: 221
  start-page: S151
  year: 2015
  ident: bib45
  article-title: MicroRNA miR-372 enhances the malignant potential of lung cancer cells
  publication-title: J. Am. Coll. Surg.
– volume: 104
  start-page: 1063
  year: 2020
  end-page: 1078
  ident: bib127
  article-title: Screening for cervical cancer
  publication-title: Med. Clin.
– volume: 124
  start-page: 1169
  year: 2006
  end-page: 1181
  ident: bib26
  article-title: A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors
  publication-title: Cell
– volume: 34
  start-page: 1985
  year: 2016
  end-page: 1991
  ident: bib29
  article-title: A miR-372/let-7 Axis regulates human germ versus somatic cell fates
  publication-title: Stem Cell.
– volume: 26
  start-page: 26
  year: 2020
  ident: bib119
  article-title: LncRNA HULC induces the progression of osteosarcoma by regulating the miR-372-3p/HMGB1 signalling axis
  publication-title: Mol. Med.
– volume: 318
  start-page: 1931
  year: 2007
  end-page: 1934
  ident: bib9
  article-title: Switching from repression to activation: microRNAs can up-regulate translation
  publication-title: Science
– volume: 28
  start-page: 521
  year: 2009
  end-page: 527
  ident: bib81
  article-title: miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2
  publication-title: Mol. Cell.
– volume: 78
  year: 2018
  ident: bib70
  article-title: miR-372 enhances tumorigenesis and drug resistance in oral carcinoma by targeting ZBTB7A transcription factor
  publication-title: Cancer Res.
– volume: 30
  start-page: e46
  year: 2019
  ident: bib130
  article-title: Immunotherapy in endometrial cancer: new scenarios on the horizon
  publication-title: J Gynecol Oncol
– volume: 19
  start-page: 510
  year: 2019
  end-page: 521
  ident: bib133
  article-title: Clinical actionability of molecular targets in endometrial cancer
  publication-title: Nat. Rev. Cancer
– volume: 23
  start-page: 1309
  year: 2018
  end-page: 1315
  ident: bib109
  article-title: MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway
  publication-title: J buon
– volume: 11
  start-page: 1
  year: 2020
  end-page: 14
  ident: bib175
  article-title: Upregulation of KCNQ1OT1 promotes resistance to stereotactic body radiotherapy in lung adenocarcinoma by inducing ATG5/ATG12-mediated autophagy via miR-372-3p
  publication-title: Cell Death Dis.
– volume: 82
  start-page: 205
  year: 2012
  end-page: 212
  ident: bib32
  article-title: MicroRNA-372 is associated with poor prognosis in colorectal cancer
  publication-title: Oncology
– volume: 7
  start-page: 6649
  year: 2016
  end-page: 6664
  ident: bib134
  article-title: MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC)
  publication-title: Oncotarget
– volume: 7
  year: 2017
  ident: bib146
  article-title: Histopathology of prostate cancer
  publication-title: Cold Spring Harb Perspect Med
– volume: 75
  start-page: 855
  year: 1993
  end-page: 862
  ident: bib12
  article-title: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans
  publication-title: Cell
– volume: 39
  start-page: 3588
  year: 2020
  end-page: 3603
  ident: bib125
  article-title: The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer
  publication-title: Oncogene
– volume: 8
  year: 2018
  ident: bib144
  article-title: The epidemiology of prostate cancer
  publication-title: Cold Spring Harb Perspect Med
– volume: 11
  start-page: 434
  year: 2016
  end-page: 443
  ident: bib157
  article-title: HOXB7 and hsa-miR-222 as the potential therapeutic candidates for metastatic colorectal cancer
  publication-title: Recent Pat. Anti-Cancer Drug Discov.
– volume: 68
  year: 2021
  ident: bib111
  article-title: Osteosarcoma
  publication-title: Pediatr. Blood Cancer
– volume: 313
  start-page: F145
  year: 2017
  end-page: f154
  ident: bib138
  article-title: Renal cell carcinoma: new insights and challenges for a clinician scientist
  publication-title: Am. J. Physiol. Ren. Physiol.
– volume: 79
  start-page: 351
  year: 2010
  end-page: 379
  ident: bib10
  article-title: Regulation of mRNA translation and stability by microRNAs
  publication-title: Annu. Rev. Biochem.
– volume: 78
  start-page: 927
  year: 2018
  end-page: 948
  ident: bib105
  article-title: Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-level, AWMF registry number 032/045OL, december 2017) - Part 1 with recommendations for the screening, diagnosis and therapy of breast cancer
  publication-title: Geburtshilfe Frauenheilkd
– volume: 38
  start-page: 259
  year: 2020
  end-page: 269
  ident: bib112
  article-title: Epidemiology and risk factors of osteosarcoma
  publication-title: Cancer Invest.
– volume: 14
  year: 2021
  ident: bib141
  article-title: The emerging role of small non-coding RNA in renal cell carcinoma
  publication-title: Transl. Oncol.
– volume: 9
  start-page: 978
  year: 2008
  end-page: 999
  ident: bib13
  article-title: MicroRNA: an emerging therapeutic target and intervention tool
  publication-title: Int. J. Mol. Sci.
– volume: 394
  start-page: 64
  year: 2019
  end-page: 80
  ident: bib50
  article-title: Nasopharyngeal carcinoma
  publication-title: Lancet
– volume: 44
  start-page: 195
  year: 2012
  end-page: 200
  ident: bib87
  article-title: MicroRNA and colorectal cancer
  publication-title: Dig. Liver Dis.
– volume: 35
  start-page: 1285
  year: 2018
  end-page: 1294
  ident: bib145
  article-title: Prostate cancer in primary care
  publication-title: Adv. Ther.
– volume: 193
  start-page: 331
  year: 2015
  end-page: 337
  ident: bib156
  article-title: Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer
  publication-title: J. Urol.
– volume: 23
  year: 2021
  ident: bib19
  article-title: Transcriptional regulation of T-bet, GATA3, ROR<gamma>T, HERV-K env, Syncytin-1, microRNA-9, 192 and 205 induced by nisin in colorectal cancer cell lines (SW480, HCT116) and human peripheral blood mononuclear cell
  publication-title: Gene Reports
– volume: 11
  year: 2023
  ident: bib5
  article-title: Evaluating state-level prescription drug monitoring program (PDMP) and pill mill effects on opioid consumption in pharmaceutical supply chain
  publication-title: Healthcare
– volume: 7
  start-page: 220
  year: 2018
  end-page: 233
  ident: bib43
  article-title: The epidemiology of lung cancer
  publication-title: Transl. Lung Cancer Res.
– volume: 20
  start-page: 24
  year: 2021
  ident: bib113
  article-title: Osteosarcoma: a review of current and future therapeutic approaches
  publication-title: Biomed. Eng. Online
– volume: 50
  start-page: 2619
  year: 2014
  end-page: 2635
  ident: bib69
  article-title: MicroRNAs and head and neck cancer: reviewing the first decade of research
  publication-title: Eur. J. Cancer
– volume: 160
  start-page: 183
  year: 2016
  end-page: 194
  ident: bib139
  article-title: Renal cell carcinoma: review of etiology, pathophysiology and risk factors
  publication-title: Biomed Pap Med. Fac. Univ. Palacky Olomouc Czech Repub
– volume: 29
  start-page: 443
  year: 2011
  end-page: 448
  ident: bib30
  article-title: Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells
  publication-title: Nat. Biotechnol.
– volume: 11
  start-page: 287
  year: 2019
  end-page: 299
  ident: bib135
  article-title: Ovarian cancer in the world: epidemiology and risk factors
  publication-title: Int J Womens Health
– volume: 38
  start-page: 5366
  year: 2010
  end-page: 5383
  ident: bib65
  article-title: CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer
  publication-title: Nucleic Acids Res.
– volume: 42
  start-page: 635
  year: 2013
  end-page: 642
  ident: bib83
  article-title: microRNA-372 maintains oncogene characteristics by targeting TNFAIP1 and affects NFκB signaling in human gastric carcinoma cells
  publication-title: Int. J. Oncol.
– volume: 8
  start-page: 712
  year: 2019
  end-page: 728
  ident: bib169
  article-title: MicroRNA‐372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK‐dependent p53 signaling pathway
  publication-title: Cancer Med.
– volume: 10
  start-page: 67
  year: 2021
  ident: bib153
  article-title: Recent advances in testicular germ cell tumours
  publication-title: Fac. Rev.
– volume: 36
  start-page: 170
  year: 2014
  end-page: 173
  ident: bib170
  article-title: Elucidating the roles of miR-372 in cell proliferation and apoptosis of nasopharyngeal carcinoma TW01 cells
  publication-title: Exp. Oncol.
– volume: 8
  start-page: 28
  year: 2020
  end-page: 37
  ident: bib126
  article-title: Cervical cancer screening: past, present, and future
  publication-title: Sex Med. Rev.
– volume: 127
  start-page: 3029
  year: 2021
  end-page: 3030
  ident: bib3
  article-title: The ever-increasing importance of cancer as a leading cause of premature death worldwide
  publication-title: Cancer
– volume: 40
  start-page: 1026
  year: 2021
  end-page: 1036
  ident: bib15
  article-title: MiR-613 promotes cell death in breast cancer cells by downregulation of nicotinamide phosphoribosyltransferase and reduction of NAD
  publication-title: DNA Cell Biol.
– volume: 19
  start-page: 3
  year: 2005
  end-page: 23
  ident: bib57
  article-title: Epidemiology and natural history of hepatocellular carcinoma
  publication-title: Best Pract. Res. Clin. Gastroenterol.
– volume: 221
  start-page: S151
  year: 2015
  ident: bib167
  article-title: MicroRNA miR-372 enhances the malignant potential of lung cancer cells
  publication-title: J. Am. Coll. Surg.
– volume: 50
  start-page: 58
  year: 2021
  end-page: 70
  ident: bib152
  article-title: Testicular germ cell tumors: serological and immunohistochemical diagnosis
  publication-title: Acta Med. Acad.
– volume: 107
  start-page: 823
  year: 2001
  end-page: 826
  ident: bib8
  article-title: microRNAs: tiny regulators with great potential
  publication-title: Cell
– volume: 33
  start-page: 2220
  year: 2012
  end-page: 2227
  ident: bib54
  article-title: Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity
  publication-title: Carcinogenesis
– volume: 2020
  start-page: 9160905
  year: 2020
  ident: bib107
  article-title: The emerging role of MicroRNAs in breast cancer
  publication-title: J. Oncol.
– volume: 48
  start-page: 593
  year: 2015
  end-page: 599
  ident: bib142
  article-title: miR-372 suppresses tumour proliferation and invasion by targeting IGF2BP1 in renal cell carcinoma
  publication-title: Cell Prolif.
– volume: 98
  start-page: 74
  year: 2003
  end-page: 80
  ident: bib53
  article-title: Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma
  publication-title: Cancer
– volume: 2
  start-page: 7
  year: 2011
  ident: bib85
  article-title: Helicobacter pylori interferes with an embryonic stem cell micro RNA cluster to block cell cycle progression
  publication-title: Silence
– volume: 21
  start-page: 246
  year: 2021
  end-page: 253
  ident: bib173
  article-title: MiR-372-3p predicts response of TACE patients treated with doxorubicin and enhances chemosensitivity in hepatocellular carcinoma
  publication-title: Anti Cancer Agents Med. Chem.
– volume: 32
  start-page: 1105
  year: 2018
  end-page: 1140
  ident: bib148
  article-title: Genetics and biology of prostate cancer
  publication-title: Genes Dev.
– volume: 16
  start-page: 7848
  year: 2017
  end-page: 7854
  ident: bib96
  article-title: Decreased expression of hsa-miR-372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1
  publication-title: Mol. Med. Rep.
– volume: 6
  start-page: 1323
  year: 2017
  end-page: 1330
  ident: bib168
  article-title: MiR‐372‐3p promotes cell growth and metastasis by targeting FGF 9 in lung squamous cell carcinoma
  publication-title: Cancer Med.
– volume: 286
  start-page: 25556
  year: 2011
  end-page: 25563
  ident: bib129
  article-title: MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and Cyclin A1 in human cervical cancer, which may contribute to tumorigenesis
  publication-title: J. Biol. Chem.
– volume: 16
  start-page: 375
  year: 2017
  end-page: 389
  ident: bib161
  article-title: miR-21, an oncogenic target miRNA for cancer therapy: molecular mechanisms and recent advancements in chemo and radio-resistance
  publication-title: Curr. Gene Ther.
– volume: 23
  start-page: 8332
  year: 2019
  end-page: 8344
  ident: bib89
  article-title: MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 108
  year: 2016
  ident: bib52
  article-title: Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma
  publication-title: J. Natl. Cancer Inst.
– volume: 25
  start-page: 6170
  year: 2006
  end-page: 6175
  ident: bib22
  article-title: MicroRNAs and the hallmarks of cancer
  publication-title: Oncogene
– volume: 18
  start-page: 1
  year: 2018
  end-page: 11
  ident: bib166
  article-title: Propofol suppresses growth, migration and invasion of A549 cells by down-regulation of miR-372
  publication-title: BMC Cancer
– volume: 6
  start-page: 857
  year: 2006
  end-page: 866
  ident: bib1
  article-title: MicroRNA signatures in human cancers
  publication-title: Nat. Rev. Cancer
– volume: 375
  start-page: 23
  year: 2013
  end-page: 30
  ident: bib33
  article-title: Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma
  publication-title: Mol. Cell. Biochem.
– volume: 397
  start-page: 428
  year: 2021
  end-page: 444
  ident: bib95
  article-title: Biliary tract cancer
  publication-title: Lancet
– volume: 160
  start-page: 744
  year: 2021
  end-page: 754
  ident: bib98
  article-title: Worldwide burden of, risk factors for, and trends in pancreatic cancer
  publication-title: Gastroenterology
– volume: 117
  start-page: 457
  year: 2009
  end-page: 464
  ident: bib25
  article-title: Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes
  publication-title: Acta Neuropathol.
– volume: 21
  start-page: 593
  year: 2020
  end-page: 598
  ident: bib16
  article-title: Intercalating the role of MicroRNAs in cancer: as enemy or protector
  publication-title: Asian Pac. J. Cancer Prev. APJCP: Asian Pac. J. Cancer Prev. APJCP
– volume: 21
  start-page: 246
  year: 2021
  end-page: 253
  ident: bib60
  article-title: MicroRNA-372-3p predicts response of TACE patients treated with doxorubicin and enhances chemosensitivity in hepatocellular carcinoma
  publication-title: Anti Cancer Agents Med. Chem.
– volume: 54
  year: 2021
  ident: bib116
  article-title: An update on the roles of circular RNAs in osteosarcoma
  publication-title: Cell Prolif.
– volume: 74
  issue: 19
  year: 2014
  ident: 10.1016/j.heliyon.2023.e15991_bib74
  article-title: Upregulation of microRNA-372 & 373 associates with cervical lymph node metastasis and poor prognosis of oral carcinomas
  publication-title: Cancer Res.
– volume: 25
  start-page: 2029
  issue: 17
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib80
  article-title: Recent advances in gastric cancer early diagnosis
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v25.i17.2029
– volume: 46
  start-page: 364
  issue: sup2
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib164
  article-title: Assessment of synergistic effect of combining hyperthermia with irradiation and calcium carbonate nanoparticles on proliferation of human breast adenocarcinoma cell line (MCF-7 cells)
  publication-title: Artif. Cells, Nanomed. Biotechnol.
  doi: 10.1080/21691401.2018.1457537
– volume: 38
  start-page: 259
  issue: 5
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib112
  article-title: Epidemiology and risk factors of osteosarcoma
  publication-title: Cancer Invest.
  doi: 10.1080/07357907.2020.1768401
– volume: 286
  start-page: 25556
  issue: 29
  year: 2011
  ident: 10.1016/j.heliyon.2023.e15991_bib129
  article-title: MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and Cyclin A1 in human cervical cancer, which may contribute to tumorigenesis
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.221564
– volume: 18
  start-page: 244
  issue: 3
  year: 2012
  ident: 10.1016/j.heliyon.2023.e15991_bib88
  article-title: The role of microRNAs in colorectal cancer
  publication-title: Cancer J.
  doi: 10.1097/PPO.0b013e318258b78f
– volume: 20
  start-page: 24
  issue: 1
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib113
  article-title: Osteosarcoma: a review of current and future therapeutic approaches
  publication-title: Biomed. Eng. Online
  doi: 10.1186/s12938-021-00860-0
– volume: 16
  start-page: 8069
  issue: 6
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib31
  article-title: microRNA-372 inhibits proliferation and induces apoptosis in human breast cancer cells by directly targeting E2F1
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2017.7591
– volume: 10
  start-page: 25
  issue: 3
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib94
  article-title: Epidemiology of gallbladder cancer in the Unites States: a population-based study
  publication-title: Chin. Clin. Oncol.
  doi: 10.21037/cco-20-230
– volume: 6
  start-page: 12
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib58
  article-title: Global incidence and mortality of liver cancers and its relationship with the human development index (HDI): an ecology study in 2018
  publication-title: World Cancer Res J
– volume: 159
  start-page: 335
  issue: 1
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib76
  article-title: Global burden of 5 major types of gastrointestinal cancer
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2020.02.068
– volume: 6
  start-page: 857
  issue: 11
  year: 2006
  ident: 10.1016/j.heliyon.2023.e15991_bib1
  article-title: MicroRNA signatures in human cancers
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1997
– volume: 23
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib19
  article-title: Transcriptional regulation of T-bet, GATA3, RORT, HERV-K env, Syncytin-1, microRNA-9, 192 and 205 induced by nisin in colorectal cancer cell lines (SW480, HCT116) and human peripheral blood mononuclear cell
  publication-title: Gene Reports
  doi: 10.1016/j.genrep.2021.101025
– volume: 94
  start-page: 471
  issue: 3
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib140
  article-title: Renal cell carcinoma for the nephrologist
  publication-title: Kidney Int.
  doi: 10.1016/j.kint.2018.01.023
– volume: 18
  start-page: 1
  issue: 1
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib166
  article-title: Propofol suppresses growth, migration and invasion of A549 cells by down-regulation of miR-372
  publication-title: BMC Cancer
  doi: 10.1186/s12885-018-5175-y
– volume: 79
  start-page: 351
  year: 2010
  ident: 10.1016/j.heliyon.2023.e15991_bib10
  article-title: Regulation of mRNA translation and stability by microRNAs
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev-biochem-060308-103103
– volume: 908
  start-page: 393
  year: 2016
  ident: 10.1016/j.heliyon.2023.e15991_bib77
  article-title: Helicobacter pylori, cancer, and the gastric microbiota
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-3-319-41388-4_19
– volume: 22
  start-page: 2598
  issue: 9
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib64
  article-title: MicroRNA-16 suppressed the invasion and migration of osteosarcoma by directly inhibiting RAB23
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 103
  start-page: 2257
  issue: 7
  year: 2006
  ident: 10.1016/j.heliyon.2023.e15991_bib79
  article-title: A microRNA expression signature of human solid tumors defines cancer gene targets
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0510565103
– volume: 35
  start-page: 1285
  issue: 9
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib145
  article-title: Prostate cancer in primary care
  publication-title: Adv. Ther.
  doi: 10.1007/s12325-018-0766-1
– volume: 604
  start-page: 17
  year: 2007
  ident: 10.1016/j.heliyon.2023.e15991_bib154
  article-title: A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-0-387-69116-9_2
– volume: 10
  start-page: 47
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib71
  article-title: The miR-372-ZBTB7A oncogenic Axis suppresses TRAIL-R2 associated drug sensitivity in oral carcinoma
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2020.00047
– volume: 21
  start-page: 246
  issue: 2
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib173
  article-title: MiR-372-3p predicts response of TACE patients treated with doxorubicin and enhances chemosensitivity in hepatocellular carcinoma
  publication-title: Anti Cancer Agents Med. Chem.
  doi: 10.2174/1871520620666200516145830
– volume: 117
  start-page: 457
  issue: 4
  year: 2009
  ident: 10.1016/j.heliyon.2023.e15991_bib25
  article-title: Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-008-0467-y
– volume: 125
  start-page: E365
  issue: 11
  year: 2015
  ident: 10.1016/j.heliyon.2023.e15991_bib73
  article-title: Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas
  publication-title: Laryngoscope
  doi: 10.1002/lary.25464
– volume: 38
  start-page: 5366
  issue: 16
  year: 2010
  ident: 10.1016/j.heliyon.2023.e15991_bib65
  article-title: CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkq285
– volume: 18
  start-page: 981
  issue: 4
  year: 2012
  ident: 10.1016/j.heliyon.2023.e15991_bib100
  article-title: MicroRNA alterations of pancreatic intraepithelial neoplasias
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-11-2347
– volume: 24
  start-page: 449
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib174
  article-title: Effects of FER1L4-miR-106a-5p/miR-372-5p-E2F1 regulatory axis on drug resistance in liver cancer chemotherapy
  publication-title: Mol. Ther. Nucleic Acids
  doi: 10.1016/j.omtn.2021.02.006
– volume: 11
  start-page: 434
  issue: 4
  year: 2016
  ident: 10.1016/j.heliyon.2023.e15991_bib157
  article-title: HOXB7 and hsa-miR-222 as the potential therapeutic candidates for metastatic colorectal cancer
  publication-title: Recent Pat. Anti-Cancer Drug Discov.
  doi: 10.2174/1574892811999160628114857
– volume: 13
  issue: 6
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib123
  article-title: Imaging and management of bladder cancer
  publication-title: Cancers
  doi: 10.3390/cancers13061396
– volume: 11
  year: 2023
  ident: 10.1016/j.heliyon.2023.e15991_bib5
  article-title: Evaluating state-level prescription drug monitoring program (PDMP) and pill mill effects on opioid consumption in pharmaceutical supply chain
  publication-title: Healthcare
  doi: 10.3390/healthcare11030437
– volume: 8
  start-page: 712
  issue: 2
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib169
  article-title: MicroRNA‐372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK‐dependent p53 signaling pathway
  publication-title: Cancer Med.
  doi: 10.1002/cam4.1924
– volume: 16
  start-page: 424
  issue: 4
  year: 2016
  ident: 10.1016/j.heliyon.2023.e15991_bib90
  article-title: Serum miR-372 is a diagnostic and prognostic biomarker in patients with early colorectal cancer
  publication-title: Anti Cancer Agents Med. Chem.
  doi: 10.2174/1871520615666150716110406
– volume: 18
  start-page: 39
  issue: 1
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib110
  article-title: Current and future therapeutic approaches for osteosarcoma
  publication-title: Expert Rev. Anticancer Ther.
  doi: 10.1080/14737140.2018.1413939
– volume: 4
  start-page: 199
  year: 2009
  ident: 10.1016/j.heliyon.2023.e15991_bib14
  article-title: MicroRNAs in cancer
  publication-title: Annu. Rev. Pathol.
  doi: 10.1146/annurev.pathol.4.110807.092222
– volume: 58
  start-page: 35
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib75
  article-title: MEHP promotes the proliferation of oral cancer cells via down regulation of miR-27b-5p and miR-372-5p
  publication-title: Toxicol. Vitro
  doi: 10.1016/j.tiv.2019.03.014
– volume: 6
  start-page: 6062
  issue: 8
  year: 2015
  ident: 10.1016/j.heliyon.2023.e15991_bib37
  article-title: miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3340
– volume: 295
  start-page: 444
  issue: 2
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib27
  article-title: The microRNAs miR-302b and miR-372 regulate mitochondrial metabolism via the SLC25A12 transporter, which controls MAVS-mediated antiviral innate immunity
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.RA119.010511
– volume: 15
  start-page: 3687
  issue: 4
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib49
  article-title: Nasopharyngeal carcinoma: a review of current updates
  publication-title: Exp. Ther. Med.
– volume: 395
  start-page: 2008
  issue: 10242
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib97
  article-title: Pancreatic cancer
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30974-0
– volume: 12
  issue: 8
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib114
  article-title: Molecular biology of osteosarcoma
  publication-title: Cancers
  doi: 10.3390/cancers12082130
– volume: 78
  start-page: 927
  issue: 10
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib105
  publication-title: Geburtshilfe Frauenheilkd
  doi: 10.1055/a-0646-4522
– volume: 6
  start-page: 1323
  issue: 6
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib46
  article-title: MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma
  publication-title: Cancer Med.
  doi: 10.1002/cam4.1026
– volume: 11
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib115
  article-title: Osteosarcoma and metastasis
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2021.780264
– volume: 28
  start-page: 1367
  issue: 16
  year: 2022
  ident: 10.1016/j.heliyon.2023.e15991_bib18
  article-title: Captopril and spironolactone can attenuate diabetic nephropathy in wistar rats by targeting ABCA1 and microRNA-33
  publication-title: Curr. Pharmaceut. Des.
  doi: 10.2174/1381612828666220401143249
– volume: 15
  start-page: 2812
  issue: 3
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib108
  article-title: miR-372 promotes breast cancer cell proliferation by directly targeting LATS2
  publication-title: Exp. Ther. Med.
– volume: 54
  issue: 1
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib116
  article-title: An update on the roles of circular RNAs in osteosarcoma
  publication-title: Cell Prolif.
  doi: 10.1111/cpr.12936
– volume: 75
  start-page: 855
  issue: 5
  year: 1993
  ident: 10.1016/j.heliyon.2023.e15991_bib12
  article-title: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans
  publication-title: Cell
  doi: 10.1016/0092-8674(93)90530-4
– volume: 69
  start-page: 438
  issue: 6
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib101
  article-title: Breast cancer statistics
  publication-title: CA A Cancer J. Clin.
– volume: 33
  start-page: 675
  issue: 4
  year: 2012
  ident: 10.1016/j.heliyon.2023.e15991_bib165
  article-title: Comparative proteomic profiling of human lung adenocarcinoma cells (CL 1–0) expressing miR‐372
  publication-title: Electrophoresis
  doi: 10.1002/elps.201100329
– volume: 160
  start-page: 744
  issue: 3
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib98
  article-title: Worldwide burden of, risk factors for, and trends in pancreatic cancer
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2020.10.007
– volume: 14
  start-page: 1
  issue: 1
  year: 2014
  ident: 10.1016/j.heliyon.2023.e15991_bib172
  article-title: miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-14-107
– volume: 127
  start-page: 3029
  issue: 16
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib3
  article-title: The ever-increasing importance of cancer as a leading cause of premature death worldwide
  publication-title: Cancer
  doi: 10.1002/cncr.33587
– volume: 32
  start-page: 605
  issue: 4
  year: 2011
  ident: 10.1016/j.heliyon.2023.e15991_bib42
  article-title: Lung cancer: epidemiology, etiology, and prevention
  publication-title: Clin. Chest Med.
  doi: 10.1016/j.ccm.2011.09.001
– volume: 13
  start-page: 6603
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib120
  article-title: MicroRNA-154: a novel candidate for diagnosis and therapy of human cancers
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S249268
– volume: 90
  start-page: 1421
  issue: 12
  year: 2012
  ident: 10.1016/j.heliyon.2023.e15991_bib92
  article-title: Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors
  publication-title: J. Mol. Med. (Berl.)
  doi: 10.1007/s00109-012-0918-8
– volume: 29
  start-page: 443
  issue: 5
  year: 2011
  ident: 10.1016/j.heliyon.2023.e15991_bib30
  article-title: Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1862
– volume: 74
  issue: 19
  year: 2014
  ident: 10.1016/j.heliyon.2023.e15991_bib72
  article-title: Hypoxia-induced miR-372 targets p62 to affect the progression of oral carcinoma
  publication-title: Cancer Res.
– volume: 496
  start-page: 104
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib128
  article-title: APOBEC: a molecular driver in cervical cancer pathogenesis
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2020.10.004
– volume: 25
  start-page: 346
  issue: 3
  year: 2014
  ident: 10.1016/j.heliyon.2023.e15991_bib91
  article-title: Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy
  publication-title: Anti Cancer Drugs
  doi: 10.1097/CAD.0000000000000049
– volume: 521
  start-page: 196
  issue: 1
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib176
  article-title: lncRNA OSER1-AS1 acts as a ceRNA to promote tumorigenesis in hepatocellular carcinoma by regulating miR-372-3p/Rab23 axis
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2019.10.105
– volume: 64
  start-page: 381
  issue: 3
  year: 2015
  ident: 10.1016/j.heliyon.2023.e15991_bib39
  article-title: Global incidence of oesophageal cancer by histological subtype in 2012
  publication-title: Gut
  doi: 10.1136/gutjnl-2014-308124
– volume: 48
  start-page: 593
  issue: 5
  year: 2015
  ident: 10.1016/j.heliyon.2023.e15991_bib142
  article-title: miR-372 suppresses tumour proliferation and invasion by targeting IGF2BP1 in renal cell carcinoma
  publication-title: Cell Prolif.
  doi: 10.1111/cpr.12207
– volume: 40
  start-page: 1026
  issue: 7
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib15
  article-title: MiR-613 promotes cell death in breast cancer cells by downregulation of nicotinamide phosphoribosyltransferase and reduction of NAD
  publication-title: DNA Cell Biol.
  doi: 10.1089/dna.2021.0330
– volume: 14
  start-page: 107
  year: 2014
  ident: 10.1016/j.heliyon.2023.e15991_bib67
  article-title: miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-14-107
– volume: 19
  start-page: 3845
  issue: 6
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib28
  article-title: Increased levels of miR-372 correlate with disease progression in patients with hyperlipidemic acute pancreatitis
  publication-title: Exp. Ther. Med.
– volume: 8
  start-page: 712
  issue: 2
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib56
  article-title: MicroRNA-372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK-dependent p53 signaling pathway
  publication-title: Cancer Med.
  doi: 10.1002/cam4.1924
– volume: 8
  issue: 1
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib122
  article-title: Epidemiology of bladder cancer
  publication-title: Med. Sci.
– volume: 624
  start-page: 14
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib137
  article-title: The role of miR-372 in ovarian carcinoma cell proliferation
  publication-title: Gene
  doi: 10.1016/j.gene.2017.04.043
– volume: 71
  start-page: 7
  issue: 1
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib2
  article-title: Cancer statistics, 2021
  publication-title: CA A Cancer J. Clin.
– volume: 42
  start-page: 635
  issue: 2
  year: 2013
  ident: 10.1016/j.heliyon.2023.e15991_bib83
  article-title: microRNA-372 maintains oncogene characteristics by targeting TNFAIP1 and affects NFκB signaling in human gastric carcinoma cells
  publication-title: Int. J. Oncol.
  doi: 10.3892/ijo.2012.1737
– volume: 98
  start-page: 74
  issue: 1
  year: 2003
  ident: 10.1016/j.heliyon.2023.e15991_bib53
  article-title: Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma
  publication-title: Cancer
  doi: 10.1002/cncr.11485
– volume: 25
  start-page: 6170
  issue: 46
  year: 2006
  ident: 10.1016/j.heliyon.2023.e15991_bib22
  article-title: MicroRNAs and the hallmarks of cancer
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209911
– volume: 68
  start-page: 394
  issue: 6
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib102
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA A Cancer J. Clin.
– volume: 104
  start-page: 1063
  issue: 6
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib127
  article-title: Screening for cervical cancer
  publication-title: Med. Clin.
– volume: 124
  start-page: 1169
  issue: 6
  year: 2006
  ident: 10.1016/j.heliyon.2023.e15991_bib26
  article-title: A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors
  publication-title: Cell
  doi: 10.1016/j.cell.2006.02.037
– volume: 221
  start-page: S151
  issue: 4
  year: 2015
  ident: 10.1016/j.heliyon.2023.e15991_bib45
  article-title: MicroRNA miR-372 enhances the malignant potential of lung cancer cells
  publication-title: J. Am. Coll. Surg.
  doi: 10.1016/j.jamcollsurg.2015.07.361
– volume: 394
  start-page: 64
  issue: 10192
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib50
  article-title: Nasopharyngeal carcinoma
  publication-title: Lancet
  doi: 10.1016/S0140-6736(19)30956-0
– volume: 28
  start-page: 397
  issue: 5
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib78
  article-title: Gastric cancer: epidemiology, biology, and prevention: a mini review
  publication-title: Eur. J. Cancer Prev.
  doi: 10.1097/CEJ.0000000000000480
– volume: 9
  start-page: 711
  issue: 3
  year: 2014
  ident: 10.1016/j.heliyon.2023.e15991_bib86
  article-title: Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules
  publication-title: ACS Chem. Biol.
  doi: 10.1021/cb400668h
– volume: 1
  start-page: 106
  issue: 3
  year: 1999
  ident: 10.1016/j.heliyon.2023.e15991_bib38
  article-title: Carcinoma of the lung and tobacco smoking: a historical perspective
  publication-title: Ochsner J.
– volume: 52
  start-page: 10
  issue: Suppl 1
  year: 2013
  ident: 10.1016/j.heliyon.2023.e15991_bib155
  article-title: Abstracts of the 65th congress of the German society for urology. September 25-28, 2013. Dresden, Germany]
  publication-title: Urologe
– volume: 11
  start-page: 1
  issue: 10
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib175
  article-title: Upregulation of KCNQ1OT1 promotes resistance to stereotactic body radiotherapy in lung adenocarcinoma by inducing ATG5/ATG12-mediated autophagy via miR-372-3p
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-020-03083-8
– volume: 38
  start-page: 5366
  issue: 16
  year: 2010
  ident: 10.1016/j.heliyon.2023.e15991_bib171
  article-title: CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkq285
– volume: 66
  issue: 4
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib48
  article-title: Emerging role of miR-372 and miR-101a in head and neck squamous cell carcinoma
  publication-title: Clin. Lab.
– volume: 33
  start-page: 675
  issue: 4
  year: 2012
  ident: 10.1016/j.heliyon.2023.e15991_bib44
  article-title: Comparative proteomic profiling of human lung adenocarcinoma cells (CL 1-0) expressing miR-372
  publication-title: Electrophoresis
  doi: 10.1002/elps.201100329
– volume: 2
  start-page: 7
  issue: 1
  year: 2011
  ident: 10.1016/j.heliyon.2023.e15991_bib85
  article-title: Helicobacter pylori interferes with an embryonic stem cell micro RNA cluster to block cell cycle progression
  publication-title: Silence
  doi: 10.1186/1758-907X-2-7
– volume: 120
  start-page: 256
  issue: 3
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib150
  article-title: Repression of MicroRNA-372 by arsenic sulphide inhibits prostate cancer cell proliferation and migration through regulation of large tumour suppressor kinase 2
  publication-title: Basic Clin. Pharmacol. Toxicol.
  doi: 10.1111/bcpt.12687
– volume: 17
  start-page: 2400
  issue: 2
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib143
  article-title: MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting ATAD2 in renal cell carcinoma
  publication-title: Oncol. Lett.
– volume: 70
  start-page: 7
  issue: 1
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib103
  article-title: Cancer statistics
  publication-title: CA A Cancer J. Clin.
– volume: 22
  start-page: 62
  issue: 1
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib117
  article-title: MiR-372-3p inhibits the growth and metastasis of osteosarcoma cells by targeting FXYD6
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 48
  start-page: 889
  issue: 3
  year: 2016
  ident: 10.1016/j.heliyon.2023.e15991_bib40
  article-title: Risk factors for lung cancer worldwide
  publication-title: Eur. Respir. J.
  doi: 10.1183/13993003.00359-2016
– volume: 6
  start-page: 1323
  issue: 6
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib168
  article-title: MiR‐372‐3p promotes cell growth and metastasis by targeting FGF 9 in lung squamous cell carcinoma
  publication-title: Cancer Med.
  doi: 10.1002/cam4.1026
– volume: 19
  start-page: 3
  issue: 1
  year: 2005
  ident: 10.1016/j.heliyon.2023.e15991_bib57
  article-title: Epidemiology and natural history of hepatocellular carcinoma
  publication-title: Best Pract. Res. Clin. Gastroenterol.
  doi: 10.1016/j.bpg.2004.10.004
– volume: 21
  start-page: 593
  issue: 3
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib16
  article-title: Intercalating the role of MicroRNAs in cancer: as enemy or protector
  publication-title: Asian Pac. J. Cancer Prev. APJCP: Asian Pac. J. Cancer Prev. APJCP
  doi: 10.31557/APJCP.2020.21.3.593
– volume: 34
  start-page: 1985
  issue: 7
  year: 2016
  ident: 10.1016/j.heliyon.2023.e15991_bib29
  article-title: A miR-372/let-7 Axis regulates human germ versus somatic cell fates
  publication-title: Stem Cell.
  doi: 10.1002/stem.2378
– volume: 66
  start-page: 7
  issue: 1
  year: 2016
  ident: 10.1016/j.heliyon.2023.e15991_bib41
  article-title: Cancer statistics
  publication-title: CA A Cancer J. Clin.
– volume: 12
  start-page: 1949
  issue: 11
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib93
  article-title: miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways
  publication-title: Mol. Oncol.
  doi: 10.1002/1878-0261.12376
– volume: 116
  start-page: 225
  issue: 2
  year: 2015
  ident: 10.1016/j.heliyon.2023.e15991_bib34
  article-title: miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.24949
– volume: 33
  start-page: 2220
  issue: 11
  year: 2012
  ident: 10.1016/j.heliyon.2023.e15991_bib54
  article-title: Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgs235
– volume: 75
  start-page: 843
  issue: 5
  year: 1993
  ident: 10.1016/j.heliyon.2023.e15991_bib11
  article-title: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
  publication-title: Cell
  doi: 10.1016/0092-8674(93)90529-Y
– volume: 78
  issue: 13
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib70
  article-title: miR-372 enhances tumorigenesis and drug resistance in oral carcinoma by targeting ZBTB7A transcription factor
  publication-title: Cancer Res.
– volume: 32
  issue: 311
  year: 2015
  ident: 10.1016/j.heliyon.2023.e15991_bib82
  article-title: The Effect of miR-372 on genome instability in MKN-45 cell line
  publication-title: J. Isfahan Med. School
– volume: 4
  start-page: e246
  issue: 7
  year: 2015
  ident: 10.1016/j.heliyon.2023.e15991_bib84
  article-title: Inhibition of gastric tumor cell growth using seed-targeting LNA as specific, long-lasting MicroRNA inhibitors
  publication-title: Mol. Ther. Nucleic Acids
  doi: 10.1038/mtna.2015.18
– volume: 16
  start-page: 375
  issue: 6
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib161
  article-title: miR-21, an oncogenic target miRNA for cancer therapy: molecular mechanisms and recent advancements in chemo and radio-resistance
  publication-title: Curr. Gene Ther.
  doi: 10.2174/1566523217666170102105119
– volume: 11
  start-page: 151
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib104
  article-title: Epidemiological characteristics of and risk factors for breast cancer in the world
  publication-title: Breast Cancer
– volume: 145
  start-page: 1719
  issue: 7
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib131
  article-title: Risk factors for endometrial cancer: an umbrella review of the literature
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.31961
– volume: 9
  start-page: 9731
  issue: 10
  year: 2015
  ident: 10.1016/j.heliyon.2023.e15991_bib158
  article-title: Systemic delivery of anti-miRNA for suppression of triple negative breast cancer utilizing RNA nanotechnology
  publication-title: ACS Nano
  doi: 10.1021/acsnano.5b02471
– volume: 50
  start-page: 2619
  issue: 15
  year: 2014
  ident: 10.1016/j.heliyon.2023.e15991_bib69
  article-title: MicroRNAs and head and neck cancer: reviewing the first decade of research
  publication-title: Eur. J. Cancer
  doi: 10.1016/j.ejca.2014.07.012
– volume: 36
  start-page: 170
  issue: 3
  year: 2014
  ident: 10.1016/j.heliyon.2023.e15991_bib55
  article-title: Elucidating the roles of miR-372 in cell proliferation and apoptosis of nasopharyngeal carcinoma TW01 cells
  publication-title: Exp. Oncol.
– volume: 107
  start-page: 823
  issue: 7
  year: 2001
  ident: 10.1016/j.heliyon.2023.e15991_bib8
  article-title: microRNAs: tiny regulators with great potential
  publication-title: Cell
  doi: 10.1016/S0092-8674(01)00616-X
– volume: 28
  start-page: 88
  issue: 1
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib121
  article-title: Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle
  publication-title: Curr. Opin. Urol.
  doi: 10.1097/MOU.0000000000000452
– volume: 15
  start-page: 182
  year: 2015
  ident: 10.1016/j.heliyon.2023.e15991_bib59
  article-title: Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma
  publication-title: BMC Cancer
  doi: 10.1186/s12885-015-1214-0
– volume: 8
  issue: 12
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib144
  article-title: The epidemiology of prostate cancer
  publication-title: Cold Spring Harb Perspect Med
  doi: 10.1101/cshperspect.a030361
– volume: 29
  start-page: 344
  issue: 4
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib151
  article-title: Genetics of testicular germ cell tumors
  publication-title: Curr. Opin. Urol.
  doi: 10.1097/MOU.0000000000000642
– volume: 10
  start-page: 67
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib153
  article-title: Recent advances in testicular germ cell tumours
  publication-title: Fac. Rev.
  doi: 10.12703/r/10-67
– volume: 23
  start-page: 3224
  issue: 5
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib35
  article-title: FER1L4/miR-372/E2F1 works as a ceRNA system to regulate the proliferation and cell cycle of glioma cells
  publication-title: J. Cell Mol. Med.
  doi: 10.1111/jcmm.14198
– volume: 160
  start-page: 183
  issue: 2
  year: 2016
  ident: 10.1016/j.heliyon.2023.e15991_bib139
  article-title: Renal cell carcinoma: review of etiology, pathophysiology and risk factors
  publication-title: Biomed Pap Med. Fac. Univ. Palacky Olomouc Czech Repub
  doi: 10.5507/bp.2015.050
– volume: 19
  start-page: eRB5996
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib20
  article-title: MicroRNAs: understanding their role in gene expression and cancer
  publication-title: Einstein (Sao Paulo)
  doi: 10.31744/einstein_journal/2021RB5996
– volume: 11
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib124
  article-title: Frontiers in bladder cancer genomic research
  publication-title: Front. Oncol.
– volume: 23
  start-page: 10
  issue: 1
  year: 2023
  ident: 10.1016/j.heliyon.2023.e15991_bib23
  article-title: Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-023-02851-8
– volume: 36
  start-page: 170
  issue: 3
  year: 2014
  ident: 10.1016/j.heliyon.2023.e15991_bib170
  article-title: Elucidating the roles of miR-372 in cell proliferation and apoptosis of nasopharyngeal carcinoma TW01 cells
  publication-title: Exp. Oncol.
– volume: 193
  start-page: 331
  issue: 1
  year: 2015
  ident: 10.1016/j.heliyon.2023.e15991_bib156
  article-title: Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2014.07.010
– volume: 35
  start-page: 828
  issue: 12
  year: 2016
  ident: 10.1016/j.heliyon.2023.e15991_bib149
  article-title: microRNA-372 suppresses migration and invasion by targeting p65 in human prostate cancer cells
  publication-title: DNA Cell Biol.
  doi: 10.1089/dna.2015.3186
– volume: 23
  start-page: 8332
  issue: 19
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib89
  article-title: MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 68
  start-page: 284
  issue: 4
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib136
  article-title: Ovarian cancer statistics
  publication-title: CA A Cancer J. Clin.
– volume: 50
  start-page: 58
  issue: 1
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib152
  article-title: Testicular germ cell tumors: serological and immunohistochemical diagnosis
  publication-title: Acta Med. Acad.
  doi: 10.5644/ama2006-124.326
– volume: 16
  start-page: 7848
  issue: 5
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib96
  article-title: Decreased expression of hsa-miR-372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2017.7520
– volume: 14
  issue: 1
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib141
  article-title: The emerging role of small non-coding RNA in renal cell carcinoma
  publication-title: Transl. Oncol.
  doi: 10.1016/j.tranon.2020.100974
– volume: 9
  start-page: 978
  issue: 6
  year: 2008
  ident: 10.1016/j.heliyon.2023.e15991_bib13
  article-title: MicroRNA: an emerging therapeutic target and intervention tool
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms9060978
– volume: 2020
  start-page: 9160905
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib107
  article-title: The emerging role of MicroRNAs in breast cancer
  publication-title: J. Oncol.
  doi: 10.1155/2020/9160905
– volume: 8
  start-page: 34429
  issue: 21
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib66
  article-title: Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.16260
– volume: 7
  start-page: 6649
  issue: 6
  year: 2016
  ident: 10.1016/j.heliyon.2023.e15991_bib134
  article-title: MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC)
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6544
– volume: 12
  start-page: 8287
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib118
  article-title: CircRNA Circ_0001721 promotes the progression of osteosarcoma through miR-372-3p/MAPK7 Axis
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S244527
– volume: 108
  issue: 1
  year: 2016
  ident: 10.1016/j.heliyon.2023.e15991_bib52
  article-title: Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/djv291
– volume: 9
  start-page: 230
  issue: 2
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib62
  article-title: Long non-coding HULC and miRNA-372 as diagnostic biomarkers in hepatocellular carcinoma
  publication-title: Rep. Biochem. Mol. Biol.
– volume: 8
  start-page: 28
  issue: 1
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib126
  article-title: Cervical cancer screening: past, present, and future
  publication-title: Sex Med. Rev.
  doi: 10.1016/j.sxmr.2019.09.005
– volume: 64
  start-page: 847
  issue: 5
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib36
  article-title: Lower expression of miR-10a in coronary artery disease and its association with pro/anti-inflammatory cytokines
  publication-title: Clin. Lab.
– volume: 26
  start-page: 677
  issue: 6
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib51
  article-title: Investigational drugs for nasopharyngeal carcinoma
  publication-title: Expet Opin. Invest. Drugs
  doi: 10.1080/13543784.2017.1324568
– volume: 82
  start-page: 205
  issue: 4
  year: 2012
  ident: 10.1016/j.heliyon.2023.e15991_bib32
  article-title: MicroRNA-372 is associated with poor prognosis in colorectal cancer
  publication-title: Oncology
  doi: 10.1159/000336809
– volume: 23
  start-page: 1309
  issue: 5
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib109
  article-title: MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway
  publication-title: J buon
– volume: 71
  start-page: 209
  issue: 3
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib4
  article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA A Cancer J. Clin.
– volume: 39
  start-page: 3588
  issue: 17
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib125
  article-title: The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer
  publication-title: Oncogene
  doi: 10.1038/s41388-020-1236-1
– volume: 521
  start-page: 196
  issue: 1
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib61
  article-title: lncRNA OSER1-AS1 acts as a ceRNA to promote tumorigenesis in hepatocellular carcinoma by regulating miR-372-3p/Rab23 axis
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2019.10.105
– volume: 28
  start-page: 521
  issue: 6
  year: 2009
  ident: 10.1016/j.heliyon.2023.e15991_bib81
  article-title: miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2
  publication-title: Mol. Cell.
  doi: 10.1007/s10059-009-0158-0
– volume: 108
  start-page: 1811
  issue: 9
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib99
  article-title: Downregulation of ULK1 by microRNA-372 inhibits the survival of human pancreatic adenocarcinoma cells
  publication-title: Cancer Sci.
  doi: 10.1111/cas.13315
– volume: 25
  start-page: 1544
  issue: 7
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib162
  article-title: RNA nanoparticle-based targeted therapy for glioblastoma through inhibition of oncogenic miR-21
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2016.11.016
– volume: 26
  start-page: 26
  issue: 1
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib119
  article-title: LncRNA HULC induces the progression of osteosarcoma by regulating the miR-372-3p/HMGB1 signalling axis
  publication-title: Mol. Med.
  doi: 10.1186/s10020-020-00155-5
– volume: 37
  start-page: 435
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib132
  article-title: Endometrial cancer: is this a new disease?
  publication-title: Am. Soc. Clin. Oncol. Educ. Book
  doi: 10.1200/EDBK_175666
– volume: 44
  start-page: 195
  issue: 3
  year: 2012
  ident: 10.1016/j.heliyon.2023.e15991_bib87
  article-title: MicroRNA and colorectal cancer
  publication-title: Dig. Liver Dis.
  doi: 10.1016/j.dld.2011.10.010
– volume: 30
  start-page: e46
  issue: 3
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib130
  article-title: Immunotherapy in endometrial cancer: new scenarios on the horizon
  publication-title: J Gynecol Oncol
  doi: 10.3802/jgo.2019.30.e46
– volume: 302
  start-page: 1
  issue: 1
  year: 2007
  ident: 10.1016/j.heliyon.2023.e15991_bib21
  article-title: microRNAs as oncogenes and tumor suppressors
  publication-title: Dev. Biol.
  doi: 10.1016/j.ydbio.2006.08.028
– volume: 68
  issue: 2
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib111
  article-title: Osteosarcoma
  publication-title: Pediatr. Blood Cancer
– volume: 32
  start-page: 1105
  issue: 17–18
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib148
  article-title: Genetics and biology of prostate cancer
  publication-title: Genes Dev.
  doi: 10.1101/gad.315739.118
– volume: 21
  start-page: 246
  issue: 2
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib60
  article-title: MicroRNA-372-3p predicts response of TACE patients treated with doxorubicin and enhances chemosensitivity in hepatocellular carcinoma
  publication-title: Anti Cancer Agents Med. Chem.
  doi: 10.2174/1871520620666200516145830
– volume: 12
  start-page: 55
  issue: 1
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib159
  article-title: Noncoding RNAs in cancer therapy resistance and targeted drug development
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-019-0748-z
– volume: 19
  start-page: 1
  issue: 1
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib63
  article-title: Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-019-0926-7
– volume: 18
  start-page: 79
  issue: 2
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib147
  article-title: Genomic and phenotypic heterogeneity in prostate cancer
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/s41585-020-00400-w
– volume: 116
  start-page: 281
  issue: 2
  year: 2004
  ident: 10.1016/j.heliyon.2023.e15991_bib7
  article-title: MicroRNAs: genomics, biogenesis, mechanism, and function
  publication-title: Cell
  doi: 10.1016/S0092-8674(04)00045-5
– volume: 22
  start-page: 424
  issue: 2
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib160
  article-title: miRNA nanotherapeutics for cancer
  publication-title: Drug Discov. Today
  doi: 10.1016/j.drudis.2016.10.014
– volume: 7
  start-page: 220
  issue: 3
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib43
  article-title: The epidemiology of lung cancer
  publication-title: Transl. Lung Cancer Res.
  doi: 10.21037/tlcr.2018.05.06
– volume: 221
  start-page: S151
  year: 2015
  ident: 10.1016/j.heliyon.2023.e15991_bib167
  article-title: MicroRNA miR-372 enhances the malignant potential of lung cancer cells
  publication-title: J. Am. Coll. Surg.
  doi: 10.1016/j.jamcollsurg.2015.07.361
– volume: 318
  start-page: 1931
  issue: 5858
  year: 2007
  ident: 10.1016/j.heliyon.2023.e15991_bib9
  article-title: Switching from repression to activation: microRNAs can up-regulate translation
  publication-title: Science
  doi: 10.1126/science.1149460
– volume: 397
  start-page: 428
  issue: 10272
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib95
  article-title: Biliary tract cancer
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00153-7
– volume: 11
  start-page: 287
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib135
  article-title: Ovarian cancer in the world: epidemiology and risk factors
  publication-title: Int J Womens Health
  doi: 10.2147/IJWH.S197604
– volume: 237
  start-page: 2309
  issue: 5
  year: 2022
  ident: 10.1016/j.heliyon.2023.e15991_bib6
  article-title: Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: mechanisms of initiation, progression, and drug sensitivity
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.30751
– volume: 24
  start-page: 449
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib68
  article-title: Effects of FER1L4-miR-106a-5p/miR-372-5p-E2F1 regulatory axis on drug resistance in liver cancer chemotherapy
  publication-title: Mol. Ther. Nucleic Acids
  doi: 10.1016/j.omtn.2021.02.006
– volume: 7
  issue: 10
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib146
  article-title: Histopathology of prostate cancer
  publication-title: Cold Spring Harb Perspect Med
  doi: 10.1101/cshperspect.a030411
– volume: 44
  year: 2020
  ident: 10.1016/j.heliyon.2023.e15991_bib17
  article-title: Dysregulation of microRNAs regulating survivin in CD4+ T cells in multiple sclerosis
  publication-title: Mult. Scler. Relat. Disord.
  doi: 10.1016/j.msard.2020.102303
– volume: 141
  year: 2021
  ident: 10.1016/j.heliyon.2023.e15991_bib24
  article-title: Dual role of microRNA-1297 in the suppression and progression of human malignancies
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2021.111863
– volume: 19
  start-page: 510
  issue: 9
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib133
  article-title: Clinical actionability of molecular targets in endometrial cancer
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-019-0177-x
– volume: 18
  start-page: 1252
  issue: 1
  year: 2018
  ident: 10.1016/j.heliyon.2023.e15991_bib47
  article-title: Propofol suppresses growth, migration and invasion of A549 cells by down-regulation of miR-372
  publication-title: BMC Cancer
  doi: 10.1186/s12885-018-5175-y
– volume: 321
  start-page: 288
  issue: 3
  year: 2019
  ident: 10.1016/j.heliyon.2023.e15991_bib106
  article-title: Breast cancer treatment: a review
  publication-title: JAMA
  doi: 10.1001/jama.2018.19323
– volume: 375
  start-page: 23
  issue: 1–2
  year: 2013
  ident: 10.1016/j.heliyon.2023.e15991_bib33
  article-title: Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma
  publication-title: Mol. Cell. Biochem.
– volume: 313
  start-page: F145
  issue: 2
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib138
  article-title: Renal cell carcinoma: new insights and challenges for a clinician scientist
  publication-title: Am. J. Physiol. Ren. Physiol.
  doi: 10.1152/ajprenal.00480.2016
– volume: 108
  start-page: 1493
  issue: 7
  year: 2017
  ident: 10.1016/j.heliyon.2023.e15991_bib163
  article-title: Co‐delivery of micro RNA‐21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy
  publication-title: Cancer Sci.
  doi: 10.1111/cas.13267
SSID ssj0001586973
Score 2.2847562
SecondaryResourceType review_article
Snippet MicroRNAs (miRNAs or miRs) are non-coding, single-stranded, endogenous RNAs that regulate various biological processes, most notably the pathophysiology of...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e15991
SubjectTerms Cancer
carcinogenesis
Function
gene expression
humans
Importance
microRNA
MicroRNA-372
neoplasm progression
neoplasms
Oncogene
oncogenes
pathophysiology
Review
therapeutics
Tumor suppressor
Title MicroRNA-372 acts as a double-edged sword in human cancers
URI https://dx.doi.org/10.1016/j.heliyon.2023.e15991
https://www.ncbi.nlm.nih.gov/pubmed/37251909
https://www.proquest.com/docview/2820970677
https://www.proquest.com/docview/2834251222
https://pubmed.ncbi.nlm.nih.gov/PMC10208947
https://doaj.org/article/b9ad90c0c26341978d1310f9825132ce
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQkRAXxJulUBmJq7deP-KY24KoKqr2UFHRm-X4oW61yqLu7oF_35k4u2xAYi9EOSXOw_PIfI7H3xDyUUnTWGUEq0L2DBm5mLUis5BzHe2kkTl22RYX1emV-natr3dKfWFOWKEHLoI7bqyPlgceRIXUY6aOE0Ak2eKSSylCwq8vxLydwVRZH1xXtptehoilWa0U_7185_h2fJPms18L5D8VcpwgpNvJIDB1_P2D-PQ3_vwzjXInLp08JU96QEmnpSPPyIPUPiePzvsp8xfk0zmm3F1eTMHJBfVhtaQedhoX62aeGP5OixQzBSOdtbQr2UcDmsLd8iW5Ovn6_csp6wsmsKArs2K6tjnGgFsVvOcND8F6JGBvpPZI2yNNFNwbr41KNkktGxBPNFkY7ZOSr8hBu2jTG0IFQheVPQxgveIS3NwqnnSuEZEATBkRtZGWCz2bOBa1mLtN2tit64XsUMiuCHlExtvLfhY6jX0XfEZVbBsjG3Z3AGzE9Tbi9tnIiNQbRboeWBTAALea7Xv-h43iHTgezqb4Ni3WSwdjVW4NEvD9q41UCCCFGJHXxVi2PQGlA3rmFl5uYEaDrg7PtLObjgAcVQD6MG__h3AOyWPsb0nifEcOVnfr9B6A1qo5Ig-nZ5c_zo4637oHI84i7g
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNA-372+acts+as+a+double-edged+sword+in+human+cancers&rft.jtitle=Heliyon&rft.au=Tajik%2C+Fatemeh&rft.au=Alian%2C+Fatemeh&rft.au=Yousefi%2C+Mohammad&rft.au=Azadfallah%2C+Ali&rft.date=2023-05-01&rft.issn=2405-8440&rft.eissn=2405-8440&rft.volume=9&rft.issue=5&rft.spage=e15991&rft_id=info:doi/10.1016%2Fj.heliyon.2023.e15991&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_heliyon_2023_e15991
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2405-8440&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2405-8440&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2405-8440&client=summon